<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE90CA04-1D62-4D88-B6C3-6C30EC90B31E"><gtr:id>AE90CA04-1D62-4D88-B6C3-6C30EC90B31E</gtr:id><gtr:name>VU University Medical Center</gtr:name><gtr:address><gtr:line1>VU University Medical Center</gtr:line1><gtr:line2>vd Boechorststraat 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A2C525FE-77BB-4CA7-9C48-D76FD97A876E"><gtr:id>A2C525FE-77BB-4CA7-9C48-D76FD97A876E</gtr:id><gtr:name>Russells Hall Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A919B771-5C0F-4AD1-B747-03D25677DC3B"><gtr:id>A919B771-5C0F-4AD1-B747-03D25677DC3B</gtr:id><gtr:name>University of Texas Southwestern Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7ABDBA44-F0B6-40FA-AA05-A5BFEAC009CD"><gtr:id>7ABDBA44-F0B6-40FA-AA05-A5BFEAC009CD</gtr:id><gtr:name>Nordic School of Public Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EAD0B76B-6C17-4533-999D-C117069E0F46"><gtr:id>EAD0B76B-6C17-4533-999D-C117069E0F46</gtr:id><gtr:name>Tokai University</gtr:name><gtr:address><gtr:line1>117 Kitakaname</gtr:line1><gtr:line2>Hiratsuka</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2D32DE23-7516-4636-BF66-19324003B62F"><gtr:id>2D32DE23-7516-4636-BF66-19324003B62F</gtr:id><gtr:name>University of Paris 13 (Paris North)</gtr:name><gtr:address><gtr:line1>Avenue Jean Baptiste</gtr:line1><gtr:line2>Clement</gtr:line2><gtr:postCode>F-93430</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68987FA0-A235-43B8-B881-7986E14EC481"><gtr:id>68987FA0-A235-43B8-B881-7986E14EC481</gtr:id><gtr:name>State University of New York</gtr:name><gtr:address><gtr:line1>1 Forestry Drive</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6EC9A5B6-77FE-4FBD-9788-DE00A59CE4EB"><gtr:id>6EC9A5B6-77FE-4FBD-9788-DE00A59CE4EB</gtr:id><gtr:name>University Hospital Vall d'Hebron</gtr:name><gtr:address><gtr:line1>Passeig Vall d'Hebron</gtr:line1><gtr:line2>119-129</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DC7658FA-443D-4B74-8143-F1800578F5B2"><gtr:id>DC7658FA-443D-4B74-8143-F1800578F5B2</gtr:id><gtr:name>New England Research Institute</gtr:name><gtr:address><gtr:line1>New England Research Institute</gtr:line1><gtr:line2>9 Galen Street</gtr:line2><gtr:postCode>MA 02472</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A97A8EC9-C79E-4701-BC21-6F259E0C8AE9"><gtr:id>A97A8EC9-C79E-4701-BC21-6F259E0C8AE9</gtr:id><gtr:name>Oslo University Hospital</gtr:name><gtr:address><gtr:line1>Ullevaal</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/677061D0-41C5-458F-9708-32A56EC6D259"><gtr:id>677061D0-41C5-458F-9708-32A56EC6D259</gtr:id><gtr:name>Georgetown University</gtr:name><gtr:address><gtr:line1>37th and O Street, NW</gtr:line1><gtr:line4>Washington</gtr:line4><gtr:line5>DC 20057</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E8E1501-62B7-4F7D-8E1B-12B9DE37117C"><gtr:id>4E8E1501-62B7-4F7D-8E1B-12B9DE37117C</gtr:id><gtr:name>Wageningen University</gtr:name><gtr:address><gtr:line1>Droevendaalsesteeg 4</gtr:line1><gtr:postCode>NL-6708 PB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7780E7DB-CA07-4C70-9022-F6ACAD15B202"><gtr:id>7780E7DB-CA07-4C70-9022-F6ACAD15B202</gtr:id><gtr:name>Sahlgrenska University Hospital</gtr:name><gtr:address><gtr:line1>Sahlgrenska Universitetssjukhuset</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAF73B42-8B6C-4BB1-9DB1-265D04E07F1C"><gtr:id>FAF73B42-8B6C-4BB1-9DB1-265D04E07F1C</gtr:id><gtr:name>Florida Atlantic University</gtr:name><gtr:address><gtr:line1>777 Glades Road</gtr:line1><gtr:line3>Boca Raton</gtr:line3><gtr:postCode>33431</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80DD41C8-30F5-4AB5-A2F4-F3285B212F89"><gtr:id>80DD41C8-30F5-4AB5-A2F4-F3285B212F89</gtr:id><gtr:name>Johns Hopkins Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9AD8EAB9-C8B5-4561-BADB-A7F9962533E1"><gtr:id>9AD8EAB9-C8B5-4561-BADB-A7F9962533E1</gtr:id><gtr:name>Rosalind Franklin University of medicine</gtr:name><gtr:address><gtr:line1>Rosalind Franklin University of med &amp; Sc</gtr:line1><gtr:line2>3333 Green Bay Road</gtr:line2><gtr:postCode>60064</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31ABE3DA-72D2-42DD-9625-40DE633EDB3E"><gtr:id>31ABE3DA-72D2-42DD-9625-40DE633EDB3E</gtr:id><gtr:name>Royal Perth Hospital</gtr:name><gtr:address><gtr:line1>Medical Research Foundation</gtr:line1><gtr:line2>Murray Street</gtr:line2><gtr:postCode>WA 6000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC20619C-24CC-4562-8F2A-B1C34FB19874"><gtr:id>FC20619C-24CC-4562-8F2A-B1C34FB19874</gtr:id><gtr:name>University Medical Centre Nijmegen</gtr:name><gtr:address><gtr:line1>Uinversity Medical Centre Nijmegen</gtr:line1><gtr:line2>PO Box 9101</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20FDE301-787F-433E-A102-D64CC1EF3508"><gtr:id>20FDE301-787F-433E-A102-D64CC1EF3508</gtr:id><gtr:name>University of Cagliari</gtr:name><gtr:address><gtr:line1>Piazza d'Armi - 09123</gtr:line1><gtr:line4>Cagliari</gtr:line4><gtr:postCode>09123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9E6AAFBD-2876-4CA6-BAC1-C649A8B1ABB4"><gtr:id>9E6AAFBD-2876-4CA6-BAC1-C649A8B1ABB4</gtr:id><gtr:name>Istituto Auxologico Italiano</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/53DED400-9F5F-46A6-8D04-62D3673B23D5"><gtr:id>53DED400-9F5F-46A6-8D04-62D3673B23D5</gtr:id><gtr:name>Catholic University Medical School</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03959A85-B42D-4E69-90CA-51CE80FF4DFC"><gtr:id>03959A85-B42D-4E69-90CA-51CE80FF4DFC</gtr:id><gtr:name>King Fahd Hospital, Saudi Arabia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7C2CC28D-286F-4939-B2B9-48A3BE2F966E"><gtr:id>7C2CC28D-286F-4939-B2B9-48A3BE2F966E</gtr:id><gtr:name>Hamilton Health Sciences</gtr:name><gtr:address><gtr:line1>1200 Main St. W</gtr:line1><gtr:postCode>L8N 3Z5</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D747F83-0211-40DF-84E7-DB44C10B03F1"><gtr:id>1D747F83-0211-40DF-84E7-DB44C10B03F1</gtr:id><gtr:name>Fred Hutchinson Cancer Research Center (FHCRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E93A8558-613B-451F-88F8-964379B61001"><gtr:id>E93A8558-613B-451F-88F8-964379B61001</gtr:id><gtr:name>Auckland City Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3466510E-8E47-4CA8-9C70-197C535E2FFC"><gtr:id>3466510E-8E47-4CA8-9C70-197C535E2FFC</gtr:id><gtr:name>University of Louisville</gtr:name><gtr:address><gtr:line1>Louisville</gtr:line1><gtr:line2>Kentucky</gtr:line2><gtr:line3>KY 40292</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58B8363B-07EB-40D9-917A-5DECE5979268"><gtr:id>58B8363B-07EB-40D9-917A-5DECE5979268</gtr:id><gtr:name>U.S. Department of Veteran Affairs</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FECCB1A9-DFD3-4152-9C27-D812D626B23B"><gtr:id>FECCB1A9-DFD3-4152-9C27-D812D626B23B</gtr:id><gtr:name>Taipei Veterans General Hospital</gtr:name><gtr:address><gtr:line1>No 201 Shih-Pai Road</gtr:line1><gtr:postCode>11217</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8DD96709-94F2-414B-BAFF-B33684D81E65"><gtr:id>8DD96709-94F2-414B-BAFF-B33684D81E65</gtr:id><gtr:name>Firat University</gtr:name><gtr:address><gtr:line1>Firat University</gtr:line1><gtr:line2>Faculty of Science and Literature</gtr:line2><gtr:postCode>23119</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F14851AB-B0F3-44C0-907D-943A0DB98A9D"><gtr:id>F14851AB-B0F3-44C0-907D-943A0DB98A9D</gtr:id><gtr:name>Uni of Texas Health Sci Ctr San Antonio</gtr:name><gtr:address><gtr:line1>7703 Floyd Curl Drive</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F9EAEAD-5674-4E30-8A06-589629F2C422"><gtr:id>0F9EAEAD-5674-4E30-8A06-589629F2C422</gtr:id><gtr:name>Haukeland University Hospital</gtr:name><gtr:address><gtr:line1>Haukeland University Hospital</gtr:line1><gtr:line2>Jonas Liesvei 65</gtr:line2><gtr:postCode>N-5021</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B94DAB96-0EAA-4E36-9FF5-62BBF51CF815"><gtr:id>B94DAB96-0EAA-4E36-9FF5-62BBF51CF815</gtr:id><gtr:name>University Hospital, Josef-Schneider-Str 2, Germany</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9F99648-1CE6-4CB7-B161-5713336BE374"><gtr:id>A9F99648-1CE6-4CB7-B161-5713336BE374</gtr:id><gtr:name>George Institute for Global Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/14B46F90-6C64-4052-AF59-495CF68F2208"><gtr:id>14B46F90-6C64-4052-AF59-495CF68F2208</gtr:id><gtr:name>Tripler Medical Army Center, US</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89833E38-8292-47CC-82C3-394FE46D889E"><gtr:id>89833E38-8292-47CC-82C3-394FE46D889E</gtr:id><gtr:name>University of Arizona</gtr:name><gtr:address><gtr:line1>617 N. Santa Rita Ave.</gtr:line1><gtr:line4>Tucson</gtr:line4><gtr:line5>Arizona</gtr:line5><gtr:postCode>AZ 85721</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D56497D-EE12-4AE3-A6E4-0754A12F1D5C"><gtr:id>5D56497D-EE12-4AE3-A6E4-0754A12F1D5C</gtr:id><gtr:name>University Hospital of North Norway</gtr:name><gtr:address><gtr:line1>PO Box 35</gtr:line1><gtr:postCode>N-9038</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF0897DD-B9A6-41F9-A9CB-B6CEA131876E"><gtr:id>EF0897DD-B9A6-41F9-A9CB-B6CEA131876E</gtr:id><gtr:name>University Hospital Cleveland</gtr:name><gtr:address><gtr:line1>University Hospital</gtr:line1><gtr:line2>11100 Euclid Avenue</gtr:line2><gtr:postCode>44106-5000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9ECFC591-7C9D-49B7-9F6E-18FAD2D94172"><gtr:id>9ECFC591-7C9D-49B7-9F6E-18FAD2D94172</gtr:id><gtr:name>University of Lyon</gtr:name><gtr:address><gtr:line1>Caserne Sergent Blandan</gtr:line1><gtr:line2>37 Rue du Repos</gtr:line2><gtr:line3>69365</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/767417B4-4A1D-444A-A608-61F7E8BDC740"><gtr:id>767417B4-4A1D-444A-A608-61F7E8BDC740</gtr:id><gtr:name>Florey Neurosciences Institute Melbourne Australia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/63F6AA61-88A8-47A3-8DDE-C79537E95B27"><gtr:id>63F6AA61-88A8-47A3-8DDE-C79537E95B27</gtr:id><gtr:name>University of Bergen</gtr:name><gtr:address><gtr:line1>University of Bergen</gtr:line1><gtr:line2>PO Box 7800</gtr:line2><gtr:line4>Bergen</gtr:line4><gtr:postCode>N-5020</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DC58B129-C07B-4751-9C68-AFDDC364C1B5"><gtr:id>DC58B129-C07B-4751-9C68-AFDDC364C1B5</gtr:id><gtr:name>Fondazione IRCCS Policlinico San Matteo</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D739677A-6514-46E5-821F-22EEA573D62A"><gtr:id>D739677A-6514-46E5-821F-22EEA573D62A</gtr:id><gtr:name>University of Ghent</gtr:name><gtr:address><gtr:line1>Rectorate Building</gtr:line1><gtr:line2>Sint-Pietersnieuwstraat 25</gtr:line2><gtr:line3>Krijgslaan</gtr:line3><gtr:postCode>B-9000</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/33DA74F3-4EF3-4BB0-BB91-18DD7C501907"><gtr:id>33DA74F3-4EF3-4BB0-BB91-18DD7C501907</gtr:id><gtr:name>Sheba Medical Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D5EE963-48CB-43EA-A3A0-D93C34A2CF48"><gtr:id>1D5EE963-48CB-43EA-A3A0-D93C34A2CF48</gtr:id><gtr:name>American University of Beirut</gtr:name><gtr:address><gtr:line1>P.O. Box 11-0236</gtr:line1><gtr:line2>Riad el-Solh</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F214B81B-2F0A-4723-B5D3-33813C4B47E5"><gtr:id>F214B81B-2F0A-4723-B5D3-33813C4B47E5</gtr:id><gtr:name>John Radcliffe Hospital</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 9DU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EA05C068-C2B7-40A4-8966-97C53890D2D0"><gtr:id>EA05C068-C2B7-40A4-8966-97C53890D2D0</gtr:id><gtr:name>Rikshospitalet , Sogsnsavvsveien</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EFED6368-AA53-4A7A-A076-B74DC8DE6C65"><gtr:id>EFED6368-AA53-4A7A-A076-B74DC8DE6C65</gtr:id><gtr:name>MAM College of Pharmacology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/581E0F16-A0E6-4EE1-9CC3-A5DCE995756E"><gtr:id>581E0F16-A0E6-4EE1-9CC3-A5DCE995756E</gtr:id><gtr:name>University of Zagreb</gtr:name><gtr:address><gtr:line1>Trg marsala Tita 14</gtr:line1><gtr:postCode>10000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/392E72B4-952B-48B3-9E56-2BCDC7F6323B"><gtr:id>392E72B4-952B-48B3-9E56-2BCDC7F6323B</gtr:id><gtr:name>Antwerp University Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AF29214D-A1C5-45E9-81A8-831E2A50ECA0"><gtr:id>AF29214D-A1C5-45E9-81A8-831E2A50ECA0</gtr:id><gtr:name>Jacksonville Centre for Clinical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE62B404-1A36-4414-A031-A8307FA6A8E8"><gtr:id>CE62B404-1A36-4414-A031-A8307FA6A8E8</gtr:id><gtr:name>Statistics Collaborative</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9BBF2AD-D2D5-4296-A280-81B197E41A13"><gtr:id>A9BBF2AD-D2D5-4296-A280-81B197E41A13</gtr:id><gtr:name>Tisch Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7CE9C29-0FC3-445E-B0D3-33AE01EC5C4C"><gtr:id>C7CE9C29-0FC3-445E-B0D3-33AE01EC5C4C</gtr:id><gtr:name>Pharma Clinical</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0EB2ECE2-59F9-4A04-B774-3F3EFD049686"><gtr:id>0EB2ECE2-59F9-4A04-B774-3F3EFD049686</gtr:id><gtr:name>Icahn School of Medicine at Mount Sinai</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4F7D98AF-1953-4119-BFAF-79160266AC69"><gtr:id>4F7D98AF-1953-4119-BFAF-79160266AC69</gtr:id><gtr:name>Ecological Institute of Caspian Sea</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/29DFFAC1-24BC-4CBD-8D5D-F30EB1063C5B"><gtr:id>29DFFAC1-24BC-4CBD-8D5D-F30EB1063C5B</gtr:id><gtr:name>ANMCO Research Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/40A7BFF7-E338-48CC-87CE-2EC5F45A6B56"><gtr:id>40A7BFF7-E338-48CC-87CE-2EC5F45A6B56</gtr:id><gtr:name>St Mary's Hospital, London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CECDEE86-7EB0-4FEC-A2D9-D3B3F8C27F0F"><gtr:id>CECDEE86-7EB0-4FEC-A2D9-D3B3F8C27F0F</gtr:id><gtr:name>Helsinki University Central Hospital</gtr:name><gtr:address><gtr:line1>Stenbackinkatu 9</gtr:line1><gtr:postCode>SF 00290</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8AE6E9DC-28D3-4E71-A432-03D5D77DC375"><gtr:id>8AE6E9DC-28D3-4E71-A432-03D5D77DC375</gtr:id><gtr:name>Hospital of Psychiatry and Psychotherapy, Germany</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FF9189E-3BFA-43DB-A18C-4694AFA42C52"><gtr:id>9FF9189E-3BFA-43DB-A18C-4694AFA42C52</gtr:id><gtr:name>University of North Texas</gtr:name><gtr:address><gtr:line1>PO Box 311277</gtr:line1><gtr:postCode>76203-128</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055E428B-EF35-46E3-83A6-4D4004294C32"><gtr:id>055E428B-EF35-46E3-83A6-4D4004294C32</gtr:id><gtr:name>University of Utah</gtr:name><gtr:address><gtr:line1>201 South Presidents Circle</gtr:line1><gtr:line2>Salt Lake City</gtr:line2><gtr:line4>Utah</gtr:line4><gtr:postCode>UT 84112</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91E7E959-69F0-401C-B3A4-AFCFB29C4F05"><gtr:id>91E7E959-69F0-401C-B3A4-AFCFB29C4F05</gtr:id><gtr:name>National Taiwan University</gtr:name><gtr:address><gtr:line1>National Taiwan University</gtr:line1><gtr:line2>Roosevelt Road</gtr:line2><gtr:line4>Taipei</gtr:line4><gtr:line5>10617</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Taiwan, Province of China</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B675328D-A78A-471F-A2F7-01A89D84A5BE"><gtr:id>B675328D-A78A-471F-A2F7-01A89D84A5BE</gtr:id><gtr:name>Mitsukoshi Health &amp; Welfare Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D545C73D-780E-4D1A-B5CD-1D6630A8CCCA"><gtr:id>D545C73D-780E-4D1A-B5CD-1D6630A8CCCA</gtr:id><gtr:name>Royal London Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/79373700-C47B-4FF3-B9A5-D151B2D9E7E5"><gtr:id>79373700-C47B-4FF3-B9A5-D151B2D9E7E5</gtr:id><gtr:name>Commission on Human Medicines (CHM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5DF5258-6FC1-4F92-928B-2E970FF914D4"><gtr:id>D5DF5258-6FC1-4F92-928B-2E970FF914D4</gtr:id><gtr:name>The University of Iowa</gtr:name><gtr:address><gtr:line1>203 Van Allen Hall</gtr:line1><gtr:line4>Iowa City</gtr:line4><gtr:line5>IA 52242-1479</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/856A7EAA-C834-4DBE-8764-98C315C40614"><gtr:id>856A7EAA-C834-4DBE-8764-98C315C40614</gtr:id><gtr:name>Mario Negri Institute for Pharmacological Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/28E35540-DAB8-4555-AF6F-09E42CBE8DB0"><gtr:id>28E35540-DAB8-4555-AF6F-09E42CBE8DB0</gtr:id><gtr:name>H?pital Bichat-Claude Bernard</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9713190C-DF10-4B7A-86C0-1FA4DC960B12"><gtr:id>9713190C-DF10-4B7A-86C0-1FA4DC960B12</gtr:id><gtr:name>Rush University Medical Center</gtr:name><gtr:address><gtr:line1>Dept of Molecular Biophysics &amp; Physiol</gtr:line1><gtr:line2>Rush University Medical Center</gtr:line2><gtr:line3>1653 West Congress Parkway</gtr:line3><gtr:line4>Chicago</gtr:line4><gtr:line5>IL 60612</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4"><gtr:id>CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4</gtr:id><gtr:name>Cedars-Sinai Medical Center</gtr:name><gtr:address><gtr:line1>8700 Beverley BI #8211</gtr:line1><gtr:postCode>90048</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4AC4427C-1C27-4665-9256-F5448806A637"><gtr:id>4AC4427C-1C27-4665-9256-F5448806A637</gtr:id><gtr:name>Maastricht University (UM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB"><gtr:id>60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB</gtr:id><gtr:name>Brigham and Women's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D73BFD76-FDDD-4BF9-A888-35BE28607789"><gtr:id>D73BFD76-FDDD-4BF9-A888-35BE28607789</gtr:id><gtr:name>Unit? de Recherche en Epid?miologie Nutritionnelle (UREN), Sorbonne-Paris-Cit?, UMR Inserm, Paris, France</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/064A41A2-AC2E-4ACC-A55B-D38D3434BD6A"><gtr:id>064A41A2-AC2E-4ACC-A55B-D38D3434BD6A</gtr:id><gtr:name>Queen's Medical Centre</gtr:name><gtr:address><gtr:line1>Queen's Medical Centre</gtr:line1><gtr:line2>Derby Rd</gtr:line2><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/60133A19-EEB2-4226-AEAD-E13B8E8A0897"><gtr:id>60133A19-EEB2-4226-AEAD-E13B8E8A0897</gtr:id><gtr:name>Royal Brompton Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/478FD190-7B12-4B03-BF76-6FEB9752F77C"><gtr:id>478FD190-7B12-4B03-BF76-6FEB9752F77C</gtr:id><gtr:name>Ulleval University Hospital</gtr:name><gtr:address><gtr:line1>Ulleval University Hospital</gtr:line1><gtr:postCode>N-0407</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5B4482BB-9926-4AE8-9C45-773E628402E1"><gtr:id>5B4482BB-9926-4AE8-9C45-773E628402E1</gtr:id><gtr:name>Sasaki Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5DB7F985-7917-4BA2-9E4A-67558A6F943E"><gtr:id>5DB7F985-7917-4BA2-9E4A-67558A6F943E</gtr:id><gtr:name>Toronto General Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A7B2862-4414-40B7-802B-2BE9A7935912"><gtr:id>0A7B2862-4414-40B7-802B-2BE9A7935912</gtr:id><gtr:name>Gastrointestinal &amp; Other Cancers Research Group</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F44FC935-8229-45D0-832A-AF35C6A449BF"><gtr:id>F44FC935-8229-45D0-832A-AF35C6A449BF</gtr:id><gtr:name>Churchill Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FDBABBE5-284C-4B87-942D-8262725355C1"><gtr:id>FDBABBE5-284C-4B87-942D-8262725355C1</gtr:id><gtr:name>Catholic University of the Sacred Heart</gtr:name><gtr:address><gtr:line1>Largo A. Gemelli</gtr:line1><gtr:postCode>20123</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F9C703E7-D83D-4394-A325-FBD9B90EC2F5"><gtr:id>F9C703E7-D83D-4394-A325-FBD9B90EC2F5</gtr:id><gtr:name>Tri-Services General Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DB0666A7-AF7B-4D83-8327-4BDA6FB41C0B"><gtr:id>DB0666A7-AF7B-4D83-8327-4BDA6FB41C0B</gtr:id><gtr:name>Government of the United States of America</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F2B788C-BBD1-49B8-A376-73334F7D7F7E"><gtr:id>6F2B788C-BBD1-49B8-A376-73334F7D7F7E</gtr:id><gtr:name>Regeneron Pharmaceuticals, Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0FE9D947-4845-4E22-A400-3C16C12C17DD"><gtr:id>0FE9D947-4845-4E22-A400-3C16C12C17DD</gtr:id><gtr:name>Thrombosis Center of Buenos Aires</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8355970-70C5-47FF-9167-7ED5E170461C"><gtr:id>A8355970-70C5-47FF-9167-7ED5E170461C</gtr:id><gtr:name>Ogun State University Teaching Hospital (OSUTH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DC1A2A87-4BDA-4D84-B209-6D8404DCA252"><gtr:id>DC1A2A87-4BDA-4D84-B209-6D8404DCA252</gtr:id><gtr:name>Seoul National University</gtr:name><gtr:address><gtr:line1>Kwanak-Gu</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/74299423-0E5D-4739-A3AA-B17137135C9B"><gtr:id>74299423-0E5D-4739-A3AA-B17137135C9B</gtr:id><gtr:name>Linkoping  University</gtr:name><gtr:address><gtr:line1>Linkoping</gtr:line1><gtr:postCode>SE-581 83</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62732F86-1081-42E9-93E7-AEDABF00169F"><gtr:id>62732F86-1081-42E9-93E7-AEDABF00169F</gtr:id><gtr:name>National Cerebral and Cardiovascular Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3F4A4BC9-38D5-470C-96C0-C6929315CA94"><gtr:id>3F4A4BC9-38D5-470C-96C0-C6929315CA94</gtr:id><gtr:name>Hennepin County Medical Center</gtr:name><gtr:address><gtr:line1>701 Park Avenue</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F5512B8-FDC1-4637-8044-5FDE4579D582"><gtr:id>6F5512B8-FDC1-4637-8044-5FDE4579D582</gtr:id><gtr:name>National Heart,?Lung, and?Blood Institute?(NHLBI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7E11AEC4-FA45-4383-B196-CFB7C53D790C"><gtr:id>7E11AEC4-FA45-4383-B196-CFB7C53D790C</gtr:id><gtr:name>Mexican Social Security Insitute (IMSS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90765748-00A7-4D14-9C5F-F34DA45F3D55"><gtr:id>90765748-00A7-4D14-9C5F-F34DA45F3D55</gtr:id><gtr:name>Western University</gtr:name><gtr:address><gtr:line1>Western University Main Campus</gtr:line1><gtr:line2>#3, Street 528</gtr:line2><gtr:line3>Sangkat Boeung Kok I, Khan Tuol Kork</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E9CEF2FB-74E5-47B4-B248-723FA54416A0"><gtr:id>E9CEF2FB-74E5-47B4-B248-723FA54416A0</gtr:id><gtr:name>BC Children's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0CC0B502-E3BF-4D55-9290-A0A96ACFB9DC"><gtr:id>0CC0B502-E3BF-4D55-9290-A0A96ACFB9DC</gtr:id><gtr:name>Schulthess Klinik</gtr:name><gtr:address><gtr:line1>Lengghalde 2</gtr:line1><gtr:postCode>CH-8008</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9D95AFAF-0F95-473D-8114-00B6A832CE18"><gtr:id>9D95AFAF-0F95-473D-8114-00B6A832CE18</gtr:id><gtr:name>University of Zaragoza</gtr:name><gtr:address><gtr:line1>Departamento de Quimica Organica</gtr:line1><gtr:line2>Facultad de Ciencias</gtr:line2><gtr:line3>Universidad de Zaragoza</gtr:line3><gtr:postCode>50009 Zara</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA"><gtr:id>7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA</gtr:id><gtr:name>University of Otago</gtr:name><gtr:address><gtr:line1>PO Box 56</gtr:line1><gtr:line4>Dunedin</gtr:line4><gtr:line5>9016</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CF11C8EB-DE92-4FC8-8F5D-477390597C44"><gtr:id>CF11C8EB-DE92-4FC8-8F5D-477390597C44</gtr:id><gtr:name>McMaster University</gtr:name><gtr:address><gtr:line1>1280 Main Street West</gtr:line1><gtr:line4>Hamilton, Ontario</gtr:line4><gtr:line5>L8S 4L8</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9ACD02BB-EC4C-4346-A6A0-801468590A83"><gtr:id>9ACD02BB-EC4C-4346-A6A0-801468590A83</gtr:id><gtr:name>Tufts University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7ABCBD06-3699-4CAE-96E2-E08FA09194AF"><gtr:id>7ABCBD06-3699-4CAE-96E2-E08FA09194AF</gtr:id><gtr:name>Beijing Huilongguan Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8C250FB6-4890-4BF9-9C23-69E6B2E02B95"><gtr:id>8C250FB6-4890-4BF9-9C23-69E6B2E02B95</gtr:id><gtr:name>Wake Forest University</gtr:name><gtr:address><gtr:line1>Wake Forest University</gtr:line1><gtr:line2>1834 Wakeforest Road</gtr:line2><gtr:line4>Winston Salem</gtr:line4><gtr:line5>North Carolina</gtr:line5><gtr:postCode>NC 27106</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1170893-AEB7-4F2F-AA16-67D6E09D2608"><gtr:id>D1170893-AEB7-4F2F-AA16-67D6E09D2608</gtr:id><gtr:name>Glasgow Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3178B45D-5F74-4CAB-BA6A-10796E718808"><gtr:id>3178B45D-5F74-4CAB-BA6A-10796E718808</gtr:id><gtr:name>VA Boston Healthcare System</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5C7AA10-15B9-4AA5-84BD-27618D717BBB"><gtr:id>F5C7AA10-15B9-4AA5-84BD-27618D717BBB</gtr:id><gtr:name>University of Chieti Pescara</gtr:name><gtr:address><gtr:line1>Via dei Vestini 31</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE90CA04-1D62-4D88-B6C3-6C30EC90B31E"><gtr:id>AE90CA04-1D62-4D88-B6C3-6C30EC90B31E</gtr:id><gtr:name>VU University Medical Center</gtr:name><gtr:address><gtr:line1>VU University Medical Center</gtr:line1><gtr:line2>vd Boechorststraat 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A2C525FE-77BB-4CA7-9C48-D76FD97A876E"><gtr:id>A2C525FE-77BB-4CA7-9C48-D76FD97A876E</gtr:id><gtr:name>Russells Hall Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A919B771-5C0F-4AD1-B747-03D25677DC3B"><gtr:id>A919B771-5C0F-4AD1-B747-03D25677DC3B</gtr:id><gtr:name>University of Texas Southwestern Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7ABDBA44-F0B6-40FA-AA05-A5BFEAC009CD"><gtr:id>7ABDBA44-F0B6-40FA-AA05-A5BFEAC009CD</gtr:id><gtr:name>Nordic School of Public Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAD0B76B-6C17-4533-999D-C117069E0F46"><gtr:id>EAD0B76B-6C17-4533-999D-C117069E0F46</gtr:id><gtr:name>Tokai University</gtr:name><gtr:address><gtr:line1>117 Kitakaname</gtr:line1><gtr:line2>Hiratsuka</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D32DE23-7516-4636-BF66-19324003B62F"><gtr:id>2D32DE23-7516-4636-BF66-19324003B62F</gtr:id><gtr:name>University of Paris 13 (Paris North)</gtr:name><gtr:address><gtr:line1>Avenue Jean Baptiste</gtr:line1><gtr:line2>Clement</gtr:line2><gtr:postCode>F-93430</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68987FA0-A235-43B8-B881-7986E14EC481"><gtr:id>68987FA0-A235-43B8-B881-7986E14EC481</gtr:id><gtr:name>State University of New York</gtr:name><gtr:address><gtr:line1>1 Forestry Drive</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6EC9A5B6-77FE-4FBD-9788-DE00A59CE4EB"><gtr:id>6EC9A5B6-77FE-4FBD-9788-DE00A59CE4EB</gtr:id><gtr:name>University Hospital Vall d'Hebron</gtr:name><gtr:address><gtr:line1>Passeig Vall d'Hebron</gtr:line1><gtr:line2>119-129</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DC7658FA-443D-4B74-8143-F1800578F5B2"><gtr:id>DC7658FA-443D-4B74-8143-F1800578F5B2</gtr:id><gtr:name>New England Research Institute</gtr:name><gtr:address><gtr:line1>New England Research Institute</gtr:line1><gtr:line2>9 Galen Street</gtr:line2><gtr:postCode>MA 02472</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A97A8EC9-C79E-4701-BC21-6F259E0C8AE9"><gtr:id>A97A8EC9-C79E-4701-BC21-6F259E0C8AE9</gtr:id><gtr:name>Oslo University Hospital</gtr:name><gtr:address><gtr:line1>Ullevaal</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/677061D0-41C5-458F-9708-32A56EC6D259"><gtr:id>677061D0-41C5-458F-9708-32A56EC6D259</gtr:id><gtr:name>Georgetown University</gtr:name><gtr:address><gtr:line1>37th and O Street, NW</gtr:line1><gtr:line4>Washington</gtr:line4><gtr:line5>DC 20057</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E8E1501-62B7-4F7D-8E1B-12B9DE37117C"><gtr:id>4E8E1501-62B7-4F7D-8E1B-12B9DE37117C</gtr:id><gtr:name>Wageningen University</gtr:name><gtr:address><gtr:line1>Droevendaalsesteeg 4</gtr:line1><gtr:postCode>NL-6708 PB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7780E7DB-CA07-4C70-9022-F6ACAD15B202"><gtr:id>7780E7DB-CA07-4C70-9022-F6ACAD15B202</gtr:id><gtr:name>Sahlgrenska University Hospital</gtr:name><gtr:address><gtr:line1>Sahlgrenska Universitetssjukhuset</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAF73B42-8B6C-4BB1-9DB1-265D04E07F1C"><gtr:id>FAF73B42-8B6C-4BB1-9DB1-265D04E07F1C</gtr:id><gtr:name>Florida Atlantic University</gtr:name><gtr:address><gtr:line1>777 Glades Road</gtr:line1><gtr:line3>Boca Raton</gtr:line3><gtr:postCode>33431</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80DD41C8-30F5-4AB5-A2F4-F3285B212F89"><gtr:id>80DD41C8-30F5-4AB5-A2F4-F3285B212F89</gtr:id><gtr:name>Johns Hopkins Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9AD8EAB9-C8B5-4561-BADB-A7F9962533E1"><gtr:id>9AD8EAB9-C8B5-4561-BADB-A7F9962533E1</gtr:id><gtr:name>Rosalind Franklin University of medicine</gtr:name><gtr:address><gtr:line1>Rosalind Franklin University of med &amp; Sc</gtr:line1><gtr:line2>3333 Green Bay Road</gtr:line2><gtr:postCode>60064</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31ABE3DA-72D2-42DD-9625-40DE633EDB3E"><gtr:id>31ABE3DA-72D2-42DD-9625-40DE633EDB3E</gtr:id><gtr:name>Royal Perth Hospital</gtr:name><gtr:address><gtr:line1>Medical Research Foundation</gtr:line1><gtr:line2>Murray Street</gtr:line2><gtr:postCode>WA 6000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC20619C-24CC-4562-8F2A-B1C34FB19874"><gtr:id>FC20619C-24CC-4562-8F2A-B1C34FB19874</gtr:id><gtr:name>University Medical Centre Nijmegen</gtr:name><gtr:address><gtr:line1>Uinversity Medical Centre Nijmegen</gtr:line1><gtr:line2>PO Box 9101</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20FDE301-787F-433E-A102-D64CC1EF3508"><gtr:id>20FDE301-787F-433E-A102-D64CC1EF3508</gtr:id><gtr:name>University of Cagliari</gtr:name><gtr:address><gtr:line1>Piazza d'Armi - 09123</gtr:line1><gtr:line4>Cagliari</gtr:line4><gtr:postCode>09123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9E6AAFBD-2876-4CA6-BAC1-C649A8B1ABB4"><gtr:id>9E6AAFBD-2876-4CA6-BAC1-C649A8B1ABB4</gtr:id><gtr:name>Istituto Auxologico Italiano</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/53DED400-9F5F-46A6-8D04-62D3673B23D5"><gtr:id>53DED400-9F5F-46A6-8D04-62D3673B23D5</gtr:id><gtr:name>Catholic University Medical School</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03959A85-B42D-4E69-90CA-51CE80FF4DFC"><gtr:id>03959A85-B42D-4E69-90CA-51CE80FF4DFC</gtr:id><gtr:name>King Fahd Hospital, Saudi Arabia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C2CC28D-286F-4939-B2B9-48A3BE2F966E"><gtr:id>7C2CC28D-286F-4939-B2B9-48A3BE2F966E</gtr:id><gtr:name>Hamilton Health Sciences</gtr:name><gtr:address><gtr:line1>1200 Main St. W</gtr:line1><gtr:postCode>L8N 3Z5</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D747F83-0211-40DF-84E7-DB44C10B03F1"><gtr:id>1D747F83-0211-40DF-84E7-DB44C10B03F1</gtr:id><gtr:name>Fred Hutchinson Cancer Research Center (FHCRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E93A8558-613B-451F-88F8-964379B61001"><gtr:id>E93A8558-613B-451F-88F8-964379B61001</gtr:id><gtr:name>Auckland City Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3466510E-8E47-4CA8-9C70-197C535E2FFC"><gtr:id>3466510E-8E47-4CA8-9C70-197C535E2FFC</gtr:id><gtr:name>University of Louisville</gtr:name><gtr:address><gtr:line1>Louisville</gtr:line1><gtr:line2>Kentucky</gtr:line2><gtr:line3>KY 40292</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58B8363B-07EB-40D9-917A-5DECE5979268"><gtr:id>58B8363B-07EB-40D9-917A-5DECE5979268</gtr:id><gtr:name>U.S. Department of Veteran Affairs</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FECCB1A9-DFD3-4152-9C27-D812D626B23B"><gtr:id>FECCB1A9-DFD3-4152-9C27-D812D626B23B</gtr:id><gtr:name>Taipei Veterans General Hospital</gtr:name><gtr:address><gtr:line1>No 201 Shih-Pai Road</gtr:line1><gtr:postCode>11217</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8DD96709-94F2-414B-BAFF-B33684D81E65"><gtr:id>8DD96709-94F2-414B-BAFF-B33684D81E65</gtr:id><gtr:name>Firat University</gtr:name><gtr:address><gtr:line1>Firat University</gtr:line1><gtr:line2>Faculty of Science and Literature</gtr:line2><gtr:postCode>23119</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F14851AB-B0F3-44C0-907D-943A0DB98A9D"><gtr:id>F14851AB-B0F3-44C0-907D-943A0DB98A9D</gtr:id><gtr:name>Uni of Texas Health Sci Ctr San Antonio</gtr:name><gtr:address><gtr:line1>7703 Floyd Curl Drive</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F9EAEAD-5674-4E30-8A06-589629F2C422"><gtr:id>0F9EAEAD-5674-4E30-8A06-589629F2C422</gtr:id><gtr:name>Haukeland University Hospital</gtr:name><gtr:address><gtr:line1>Haukeland University Hospital</gtr:line1><gtr:line2>Jonas Liesvei 65</gtr:line2><gtr:postCode>N-5021</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B94DAB96-0EAA-4E36-9FF5-62BBF51CF815"><gtr:id>B94DAB96-0EAA-4E36-9FF5-62BBF51CF815</gtr:id><gtr:name>University Hospital, Josef-Schneider-Str 2, Germany</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9F99648-1CE6-4CB7-B161-5713336BE374"><gtr:id>A9F99648-1CE6-4CB7-B161-5713336BE374</gtr:id><gtr:name>George Institute for Global Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/14B46F90-6C64-4052-AF59-495CF68F2208"><gtr:id>14B46F90-6C64-4052-AF59-495CF68F2208</gtr:id><gtr:name>Tripler Medical Army Center, US</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89833E38-8292-47CC-82C3-394FE46D889E"><gtr:id>89833E38-8292-47CC-82C3-394FE46D889E</gtr:id><gtr:name>University of Arizona</gtr:name><gtr:address><gtr:line1>617 N. Santa Rita Ave.</gtr:line1><gtr:line4>Tucson</gtr:line4><gtr:line5>Arizona</gtr:line5><gtr:postCode>AZ 85721</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D56497D-EE12-4AE3-A6E4-0754A12F1D5C"><gtr:id>5D56497D-EE12-4AE3-A6E4-0754A12F1D5C</gtr:id><gtr:name>University Hospital of North Norway</gtr:name><gtr:address><gtr:line1>PO Box 35</gtr:line1><gtr:postCode>N-9038</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF0897DD-B9A6-41F9-A9CB-B6CEA131876E"><gtr:id>EF0897DD-B9A6-41F9-A9CB-B6CEA131876E</gtr:id><gtr:name>University Hospital Cleveland</gtr:name><gtr:address><gtr:line1>University Hospital</gtr:line1><gtr:line2>11100 Euclid Avenue</gtr:line2><gtr:postCode>44106-5000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9ECFC591-7C9D-49B7-9F6E-18FAD2D94172"><gtr:id>9ECFC591-7C9D-49B7-9F6E-18FAD2D94172</gtr:id><gtr:name>University of Lyon</gtr:name><gtr:address><gtr:line1>Caserne Sergent Blandan</gtr:line1><gtr:line2>37 Rue du Repos</gtr:line2><gtr:line3>69365</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/767417B4-4A1D-444A-A608-61F7E8BDC740"><gtr:id>767417B4-4A1D-444A-A608-61F7E8BDC740</gtr:id><gtr:name>Florey Neurosciences Institute Melbourne Australia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63F6AA61-88A8-47A3-8DDE-C79537E95B27"><gtr:id>63F6AA61-88A8-47A3-8DDE-C79537E95B27</gtr:id><gtr:name>University of Bergen</gtr:name><gtr:address><gtr:line1>University of Bergen</gtr:line1><gtr:line2>PO Box 7800</gtr:line2><gtr:line4>Bergen</gtr:line4><gtr:postCode>N-5020</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DC58B129-C07B-4751-9C68-AFDDC364C1B5"><gtr:id>DC58B129-C07B-4751-9C68-AFDDC364C1B5</gtr:id><gtr:name>Fondazione IRCCS Policlinico San Matteo</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D739677A-6514-46E5-821F-22EEA573D62A"><gtr:id>D739677A-6514-46E5-821F-22EEA573D62A</gtr:id><gtr:name>University of Ghent</gtr:name><gtr:address><gtr:line1>Rectorate Building</gtr:line1><gtr:line2>Sint-Pietersnieuwstraat 25</gtr:line2><gtr:line3>Krijgslaan</gtr:line3><gtr:postCode>B-9000</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/33DA74F3-4EF3-4BB0-BB91-18DD7C501907"><gtr:id>33DA74F3-4EF3-4BB0-BB91-18DD7C501907</gtr:id><gtr:name>Sheba Medical Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D5EE963-48CB-43EA-A3A0-D93C34A2CF48"><gtr:id>1D5EE963-48CB-43EA-A3A0-D93C34A2CF48</gtr:id><gtr:name>American University of Beirut</gtr:name><gtr:address><gtr:line1>P.O. Box 11-0236</gtr:line1><gtr:line2>Riad el-Solh</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F214B81B-2F0A-4723-B5D3-33813C4B47E5"><gtr:id>F214B81B-2F0A-4723-B5D3-33813C4B47E5</gtr:id><gtr:name>John Radcliffe Hospital</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 9DU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EA05C068-C2B7-40A4-8966-97C53890D2D0"><gtr:id>EA05C068-C2B7-40A4-8966-97C53890D2D0</gtr:id><gtr:name>Rikshospitalet , Sogsnsavvsveien</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EFED6368-AA53-4A7A-A076-B74DC8DE6C65"><gtr:id>EFED6368-AA53-4A7A-A076-B74DC8DE6C65</gtr:id><gtr:name>MAM College of Pharmacology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/581E0F16-A0E6-4EE1-9CC3-A5DCE995756E"><gtr:id>581E0F16-A0E6-4EE1-9CC3-A5DCE995756E</gtr:id><gtr:name>University of Zagreb</gtr:name><gtr:address><gtr:line1>Trg marsala Tita 14</gtr:line1><gtr:postCode>10000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/392E72B4-952B-48B3-9E56-2BCDC7F6323B"><gtr:id>392E72B4-952B-48B3-9E56-2BCDC7F6323B</gtr:id><gtr:name>Antwerp University Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AF29214D-A1C5-45E9-81A8-831E2A50ECA0"><gtr:id>AF29214D-A1C5-45E9-81A8-831E2A50ECA0</gtr:id><gtr:name>Jacksonville Centre for Clinical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE62B404-1A36-4414-A031-A8307FA6A8E8"><gtr:id>CE62B404-1A36-4414-A031-A8307FA6A8E8</gtr:id><gtr:name>Statistics Collaborative</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9BBF2AD-D2D5-4296-A280-81B197E41A13"><gtr:id>A9BBF2AD-D2D5-4296-A280-81B197E41A13</gtr:id><gtr:name>Tisch Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7CE9C29-0FC3-445E-B0D3-33AE01EC5C4C"><gtr:id>C7CE9C29-0FC3-445E-B0D3-33AE01EC5C4C</gtr:id><gtr:name>Pharma Clinical</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0EB2ECE2-59F9-4A04-B774-3F3EFD049686"><gtr:id>0EB2ECE2-59F9-4A04-B774-3F3EFD049686</gtr:id><gtr:name>Icahn School of Medicine at Mount Sinai</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4F7D98AF-1953-4119-BFAF-79160266AC69"><gtr:id>4F7D98AF-1953-4119-BFAF-79160266AC69</gtr:id><gtr:name>Ecological Institute of Caspian Sea</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/29DFFAC1-24BC-4CBD-8D5D-F30EB1063C5B"><gtr:id>29DFFAC1-24BC-4CBD-8D5D-F30EB1063C5B</gtr:id><gtr:name>ANMCO Research Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/40A7BFF7-E338-48CC-87CE-2EC5F45A6B56"><gtr:id>40A7BFF7-E338-48CC-87CE-2EC5F45A6B56</gtr:id><gtr:name>St Mary's Hospital, London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CECDEE86-7EB0-4FEC-A2D9-D3B3F8C27F0F"><gtr:id>CECDEE86-7EB0-4FEC-A2D9-D3B3F8C27F0F</gtr:id><gtr:name>Helsinki University Central Hospital</gtr:name><gtr:address><gtr:line1>Stenbackinkatu 9</gtr:line1><gtr:postCode>SF 00290</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8AE6E9DC-28D3-4E71-A432-03D5D77DC375"><gtr:id>8AE6E9DC-28D3-4E71-A432-03D5D77DC375</gtr:id><gtr:name>Hospital of Psychiatry and Psychotherapy, Germany</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FF9189E-3BFA-43DB-A18C-4694AFA42C52"><gtr:id>9FF9189E-3BFA-43DB-A18C-4694AFA42C52</gtr:id><gtr:name>University of North Texas</gtr:name><gtr:address><gtr:line1>PO Box 311277</gtr:line1><gtr:postCode>76203-128</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055E428B-EF35-46E3-83A6-4D4004294C32"><gtr:id>055E428B-EF35-46E3-83A6-4D4004294C32</gtr:id><gtr:name>University of Utah</gtr:name><gtr:address><gtr:line1>201 South Presidents Circle</gtr:line1><gtr:line2>Salt Lake City</gtr:line2><gtr:line4>Utah</gtr:line4><gtr:postCode>UT 84112</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91E7E959-69F0-401C-B3A4-AFCFB29C4F05"><gtr:id>91E7E959-69F0-401C-B3A4-AFCFB29C4F05</gtr:id><gtr:name>National Taiwan University</gtr:name><gtr:address><gtr:line1>National Taiwan University</gtr:line1><gtr:line2>Roosevelt Road</gtr:line2><gtr:line4>Taipei</gtr:line4><gtr:line5>10617</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Taiwan, Province of China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B675328D-A78A-471F-A2F7-01A89D84A5BE"><gtr:id>B675328D-A78A-471F-A2F7-01A89D84A5BE</gtr:id><gtr:name>Mitsukoshi Health &amp; Welfare Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D545C73D-780E-4D1A-B5CD-1D6630A8CCCA"><gtr:id>D545C73D-780E-4D1A-B5CD-1D6630A8CCCA</gtr:id><gtr:name>Royal London Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/79373700-C47B-4FF3-B9A5-D151B2D9E7E5"><gtr:id>79373700-C47B-4FF3-B9A5-D151B2D9E7E5</gtr:id><gtr:name>Commission on Human Medicines (CHM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5DF5258-6FC1-4F92-928B-2E970FF914D4"><gtr:id>D5DF5258-6FC1-4F92-928B-2E970FF914D4</gtr:id><gtr:name>The University of Iowa</gtr:name><gtr:address><gtr:line1>203 Van Allen Hall</gtr:line1><gtr:line4>Iowa City</gtr:line4><gtr:line5>IA 52242-1479</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/856A7EAA-C834-4DBE-8764-98C315C40614"><gtr:id>856A7EAA-C834-4DBE-8764-98C315C40614</gtr:id><gtr:name>Mario Negri Institute for Pharmacological Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/28E35540-DAB8-4555-AF6F-09E42CBE8DB0"><gtr:id>28E35540-DAB8-4555-AF6F-09E42CBE8DB0</gtr:id><gtr:name>H?pital Bichat-Claude Bernard</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9713190C-DF10-4B7A-86C0-1FA4DC960B12"><gtr:id>9713190C-DF10-4B7A-86C0-1FA4DC960B12</gtr:id><gtr:name>Rush University Medical Center</gtr:name><gtr:address><gtr:line1>Dept of Molecular Biophysics &amp; Physiol</gtr:line1><gtr:line2>Rush University Medical Center</gtr:line2><gtr:line3>1653 West Congress Parkway</gtr:line3><gtr:line4>Chicago</gtr:line4><gtr:line5>IL 60612</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4"><gtr:id>CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4</gtr:id><gtr:name>Cedars-Sinai Medical Center</gtr:name><gtr:address><gtr:line1>8700 Beverley BI #8211</gtr:line1><gtr:postCode>90048</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4AC4427C-1C27-4665-9256-F5448806A637"><gtr:id>4AC4427C-1C27-4665-9256-F5448806A637</gtr:id><gtr:name>Maastricht University (UM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB"><gtr:id>60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB</gtr:id><gtr:name>Brigham and Women's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D73BFD76-FDDD-4BF9-A888-35BE28607789"><gtr:id>D73BFD76-FDDD-4BF9-A888-35BE28607789</gtr:id><gtr:name>Unit? de Recherche en Epid?miologie Nutritionnelle (UREN), Sorbonne-Paris-Cit?, UMR Inserm, Paris, France</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/064A41A2-AC2E-4ACC-A55B-D38D3434BD6A"><gtr:id>064A41A2-AC2E-4ACC-A55B-D38D3434BD6A</gtr:id><gtr:name>Queen's Medical Centre</gtr:name><gtr:address><gtr:line1>Queen's Medical Centre</gtr:line1><gtr:line2>Derby Rd</gtr:line2><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60133A19-EEB2-4226-AEAD-E13B8E8A0897"><gtr:id>60133A19-EEB2-4226-AEAD-E13B8E8A0897</gtr:id><gtr:name>Royal Brompton Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/478FD190-7B12-4B03-BF76-6FEB9752F77C"><gtr:id>478FD190-7B12-4B03-BF76-6FEB9752F77C</gtr:id><gtr:name>Ulleval University Hospital</gtr:name><gtr:address><gtr:line1>Ulleval University Hospital</gtr:line1><gtr:postCode>N-0407</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B4482BB-9926-4AE8-9C45-773E628402E1"><gtr:id>5B4482BB-9926-4AE8-9C45-773E628402E1</gtr:id><gtr:name>Sasaki Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5DB7F985-7917-4BA2-9E4A-67558A6F943E"><gtr:id>5DB7F985-7917-4BA2-9E4A-67558A6F943E</gtr:id><gtr:name>Toronto General Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A7B2862-4414-40B7-802B-2BE9A7935912"><gtr:id>0A7B2862-4414-40B7-802B-2BE9A7935912</gtr:id><gtr:name>Gastrointestinal &amp; Other Cancers Research Group</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F44FC935-8229-45D0-832A-AF35C6A449BF"><gtr:id>F44FC935-8229-45D0-832A-AF35C6A449BF</gtr:id><gtr:name>Churchill Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FDBABBE5-284C-4B87-942D-8262725355C1"><gtr:id>FDBABBE5-284C-4B87-942D-8262725355C1</gtr:id><gtr:name>Catholic University of the Sacred Heart</gtr:name><gtr:address><gtr:line1>Largo A. Gemelli</gtr:line1><gtr:postCode>20123</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F9C703E7-D83D-4394-A325-FBD9B90EC2F5"><gtr:id>F9C703E7-D83D-4394-A325-FBD9B90EC2F5</gtr:id><gtr:name>Tri-Services General Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DB0666A7-AF7B-4D83-8327-4BDA6FB41C0B"><gtr:id>DB0666A7-AF7B-4D83-8327-4BDA6FB41C0B</gtr:id><gtr:name>Government of the United States of America</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F2B788C-BBD1-49B8-A376-73334F7D7F7E"><gtr:id>6F2B788C-BBD1-49B8-A376-73334F7D7F7E</gtr:id><gtr:name>Regeneron Pharmaceuticals, Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0FE9D947-4845-4E22-A400-3C16C12C17DD"><gtr:id>0FE9D947-4845-4E22-A400-3C16C12C17DD</gtr:id><gtr:name>Thrombosis Center of Buenos Aires</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8355970-70C5-47FF-9167-7ED5E170461C"><gtr:id>A8355970-70C5-47FF-9167-7ED5E170461C</gtr:id><gtr:name>Ogun State University Teaching Hospital (OSUTH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DC1A2A87-4BDA-4D84-B209-6D8404DCA252"><gtr:id>DC1A2A87-4BDA-4D84-B209-6D8404DCA252</gtr:id><gtr:name>Seoul National University</gtr:name><gtr:address><gtr:line1>Kwanak-Gu</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/74299423-0E5D-4739-A3AA-B17137135C9B"><gtr:id>74299423-0E5D-4739-A3AA-B17137135C9B</gtr:id><gtr:name>Linkoping  University</gtr:name><gtr:address><gtr:line1>Linkoping</gtr:line1><gtr:postCode>SE-581 83</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62732F86-1081-42E9-93E7-AEDABF00169F"><gtr:id>62732F86-1081-42E9-93E7-AEDABF00169F</gtr:id><gtr:name>National Cerebral and Cardiovascular Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3F4A4BC9-38D5-470C-96C0-C6929315CA94"><gtr:id>3F4A4BC9-38D5-470C-96C0-C6929315CA94</gtr:id><gtr:name>Hennepin County Medical Center</gtr:name><gtr:address><gtr:line1>701 Park Avenue</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F5512B8-FDC1-4637-8044-5FDE4579D582"><gtr:id>6F5512B8-FDC1-4637-8044-5FDE4579D582</gtr:id><gtr:name>National Heart,?Lung, and?Blood Institute?(NHLBI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7E11AEC4-FA45-4383-B196-CFB7C53D790C"><gtr:id>7E11AEC4-FA45-4383-B196-CFB7C53D790C</gtr:id><gtr:name>Mexican Social Security Insitute (IMSS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90765748-00A7-4D14-9C5F-F34DA45F3D55"><gtr:id>90765748-00A7-4D14-9C5F-F34DA45F3D55</gtr:id><gtr:name>Western University</gtr:name><gtr:address><gtr:line1>Western University Main Campus</gtr:line1><gtr:line2>#3, Street 528</gtr:line2><gtr:line3>Sangkat Boeung Kok I, Khan Tuol Kork</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E9CEF2FB-74E5-47B4-B248-723FA54416A0"><gtr:id>E9CEF2FB-74E5-47B4-B248-723FA54416A0</gtr:id><gtr:name>BC Children's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0CC0B502-E3BF-4D55-9290-A0A96ACFB9DC"><gtr:id>0CC0B502-E3BF-4D55-9290-A0A96ACFB9DC</gtr:id><gtr:name>Schulthess Klinik</gtr:name><gtr:address><gtr:line1>Lengghalde 2</gtr:line1><gtr:postCode>CH-8008</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9D95AFAF-0F95-473D-8114-00B6A832CE18"><gtr:id>9D95AFAF-0F95-473D-8114-00B6A832CE18</gtr:id><gtr:name>University of Zaragoza</gtr:name><gtr:address><gtr:line1>Departamento de Quimica Organica</gtr:line1><gtr:line2>Facultad de Ciencias</gtr:line2><gtr:line3>Universidad de Zaragoza</gtr:line3><gtr:postCode>50009 Zara</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA"><gtr:id>7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA</gtr:id><gtr:name>University of Otago</gtr:name><gtr:address><gtr:line1>PO Box 56</gtr:line1><gtr:line4>Dunedin</gtr:line4><gtr:line5>9016</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CF11C8EB-DE92-4FC8-8F5D-477390597C44"><gtr:id>CF11C8EB-DE92-4FC8-8F5D-477390597C44</gtr:id><gtr:name>McMaster University</gtr:name><gtr:address><gtr:line1>1280 Main Street West</gtr:line1><gtr:line4>Hamilton, Ontario</gtr:line4><gtr:line5>L8S 4L8</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9ACD02BB-EC4C-4346-A6A0-801468590A83"><gtr:id>9ACD02BB-EC4C-4346-A6A0-801468590A83</gtr:id><gtr:name>Tufts University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7ABCBD06-3699-4CAE-96E2-E08FA09194AF"><gtr:id>7ABCBD06-3699-4CAE-96E2-E08FA09194AF</gtr:id><gtr:name>Beijing Huilongguan Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8C250FB6-4890-4BF9-9C23-69E6B2E02B95"><gtr:id>8C250FB6-4890-4BF9-9C23-69E6B2E02B95</gtr:id><gtr:name>Wake Forest University</gtr:name><gtr:address><gtr:line1>Wake Forest University</gtr:line1><gtr:line2>1834 Wakeforest Road</gtr:line2><gtr:line4>Winston Salem</gtr:line4><gtr:line5>North Carolina</gtr:line5><gtr:postCode>NC 27106</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1170893-AEB7-4F2F-AA16-67D6E09D2608"><gtr:id>D1170893-AEB7-4F2F-AA16-67D6E09D2608</gtr:id><gtr:name>Glasgow Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3178B45D-5F74-4CAB-BA6A-10796E718808"><gtr:id>3178B45D-5F74-4CAB-BA6A-10796E718808</gtr:id><gtr:name>VA Boston Healthcare System</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5C7AA10-15B9-4AA5-84BD-27618D717BBB"><gtr:id>F5C7AA10-15B9-4AA5-84BD-27618D717BBB</gtr:id><gtr:name>University of Chieti Pescara</gtr:name><gtr:address><gtr:line1>Via dei Vestini 31</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0E4CA39F-CC6B-4706-BBC4-D8FF62841C8C"><gtr:id>0E4CA39F-CC6B-4706-BBC4-D8FF62841C8C</gtr:id><gtr:firstName>Lisa</gtr:firstName><gtr:surname>Blackwell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0D27F3FA-02E2-4379-83AF-B946487C1AAE"><gtr:id>0D27F3FA-02E2-4379-83AF-B946487C1AAE</gtr:id><gtr:firstName>Kate</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Bird</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C71A2E42-A9DC-488F-A778-FDE8AA4B4299"><gtr:id>C71A2E42-A9DC-488F-A778-FDE8AA4B4299</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>XJ</gtr:otherNames><gtr:surname>Wong</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6EC630CA-FF9A-47B3-A931-3C3D88D1D087"><gtr:id>6EC630CA-FF9A-47B3-A931-3C3D88D1D087</gtr:id><gtr:firstName>Lisa</gtr:firstName><gtr:surname>Holland</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/90232D94-C2A5-4E0C-9214-D1F2E407E8B7"><gtr:id>90232D94-C2A5-4E0C-9214-D1F2E407E8B7</gtr:id><gtr:firstName>Christine</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Reith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E8CC3F5A-852B-4667-B688-4DB230277AB3"><gtr:id>E8CC3F5A-852B-4667-B688-4DB230277AB3</gtr:id><gtr:firstName>Heather</gtr:firstName><gtr:surname>Halls</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/42EA1F7C-61E8-4457-99C1-1437D6FEC7F6"><gtr:id>42EA1F7C-61E8-4457-99C1-1437D6FEC7F6</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Bulbulia</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F4479AD7-66C1-4474-8AB6-E8F33ACCEBC0"><gtr:id>F4479AD7-66C1-4474-8AB6-E8F33ACCEBC0</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Baigent</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/10D9EDDD-90BD-45A5-B620-831BC7AC90EC"><gtr:id>10D9EDDD-90BD-45A5-B620-831BC7AC90EC</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Emberson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C3A08924-3211-47F9-A709-DC28DAD85A96"><gtr:id>C3A08924-3211-47F9-A709-DC28DAD85A96</gtr:id><gtr:firstName>Rory</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137686849"><gtr:id>773C6291-DF28-446F-9B13-9E1185ABED62</gtr:id><gtr:title>Determining the effects of treatments on vascular disease risk by meta-analyses using individual participant data</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137686849</gtr:grantReference><gtr:abstractText>This programme of research provides reliable evidence of the effects of treatment with common drugs, such as aspirin, other painkillers (NSAIDs), and statins. Since the effects of commonly used treatments are often modest, but important in terms of their long-term health consequences, studies generally require data on very large numbers of patients. Individual clinical trials on their own on such drugs are too small to assess such effects reliably, so we use a method called meta-analysis to examine aggregated data from all relevant trials. This involves collaborating with other scientists worldwide who have undertaken such trials, securing their agreement to provide the individual patient data, and then analysing this large amount of individual patient level data from the various trials to develop a more detailed understanding of the effects of particular treatments. For example, our previous work has helped to provide guidance on which people benefit from aspirin and statins, and has also provided useful information about the risks of NSAIDs. The results of these collaborative studies are widely used to guide doctors in the use of drug treatments internationally, and also help to identify which areas of research are required to tackle outstanding clinical questions.</gtr:abstractText><gtr:technicalSummary>This programme of research determines the effects of common treatments, such as non-steroidal anti-inflammatory drugs (NSAIDs) and statins, on the risk of vascular disease, whether as an intended benefit or as an unanticipated hazard, by conducting meta-analyses. We coordinate collaborations of trialists to conduct meta-analyses, using individual participant data contributed by investigators and sponsors, but analysed independently of the funding source of the trials. In each of the various collaborations, the effects and safety of the treatment under study can be assessed more reliably through the use of data from individual participants. In particular, it is possible to examine the effects of treatments on particular outcomes (with broadly similar definitions across different studies), assess possible variation in the effects of treatments in different types of patients, and assess the temporal evolution of treatment effects in relation to drug use. Our previous work has helped to resolve significant uncertainties about the treatment of common conditions in different patient groups. For example, the Antithrombotic Treatment Trialists? (ATT) Collaboration has shown that, among patients who already have occlusive vascular disease, long-term antiplatelet therapy (e.g. with aspirin) reduces the annual risk of serious vascular event by about a quarter. This typically corresponds to an absolute reduction of about 10-20 per 1000 in the annual incidence of serious vascular events. Against this benefit, the absolute increase in major gastrointestinal or other major extracranial bleeds is about ten times smaller. Hence, for secondary prevention, it is widely agreed that the benefit of aspirin substantially exceeds risk. For primary prevention, however, the balance is less clear because the absolute vascular benefits of aspirin are an order of magnitude lower in this setting than in secondary prevention, and our work has shown that aspirin is not appropriate for primary prevention. Similarly, the Coxib and traditional NSAIDs Trialists? (CNT) Collaboration has helped quantify the cardiovascular and gastrointestinal risks of non-steroidal anti-inflammatory drugs, which led to changes in drug-labelling for diclofenac in Europe, and the Cholesterol Treatment Trialists? [CTT] Collaboration has documented the benefits and safety of statin therapy in a wide variety of people, including people at low risk of vascular disease, again influencing guidelines worldwide. Future work will address areas of uncertainty within existing meta-analyses (including, within the CTT for example, analyses of adverse events within trials of statin therapy), as well as tackling new questions, such as the balance of benefit and risk of rt-PA in ischaemic stroke within the Stroke Thrombolysis Trialists? (STT) Collaboration.</gtr:technicalSummary><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1881834</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oslo University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>5AA06253-D817-4160-8508-AD4D57E3783F</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-4</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Catholic University of the Sacred Heart</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>School of Medicine (UCSC)</gtr:department><gtr:description>Antithrombotic Treatment Trialists' (ATT) Collaboration</gtr:description><gtr:id>044941C8-0841-43DD-B225-AE7F1F3D3403</gtr:id><gtr:impact>Our 2009 Lancet publication (373: 1849-60) has been very highly cited (over 650 citations to date) , is widely incorporated into treatment guidelines worldwide, and resulted in the MHRA issuing a warning against aspirin use for primary prevention (http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087716).</gtr:impact><gtr:outcomeId>54183e7975cdb7.39916488-4</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating aspirin for the primary prevention of vascular disease. Data are now available on 95,000 patients in 6 trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Epidemiology and Public Health</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>C2E843E3-CCE4-42B8-9B53-C050DE4E6217</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-13</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oslo University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Cardiology</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>EA58FA8C-2573-411A-B937-1DFFB013A2C8</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-42</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Zaragoza</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>E903B3B7-0726-46A1-9559-A92917ED2755</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-14</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Schulthess Klinik</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>51992C69-A59F-4C37-BAB0-7FC107DC4E2C</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-28</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Firat University</gtr:collaboratingOrganisation><gtr:country>Turkey, Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>67E2B862-7466-4713-B849-937652FC8BA5</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-44</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mario Negri Institute for Pharmacological Research</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Consorzio Mario Negri Sud (CMNS)</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>7A0B9BAF-E21D-4F36-9A28-C72ECEF3DDE7</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-6</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>742265AE-AD8A-462E-80AF-AC3771B303AC</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-16</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Carolina at Chapel Hill</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>UNC School of Medicine</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>0A6A2E6B-112D-45B3-8AA7-244C6C6DE09D</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-12</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tufts University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Dental Medicine</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>EB7261BD-0E9D-4029-98D8-33D1E98C0634</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-45</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Glasgow</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>3425DE59-AAE6-46BD-B210-D08E2DC18659</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-26</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>EB15D767-3CB8-4FB5-8C55-510F737EEFC3</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-37</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokai University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>64E2E35C-C24D-46C8-9B2D-15B8A6B14F58</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-11</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Johns Hopkins Bloomberg School of Public Health</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>05BB00C7-113C-47CD-B4FA-83D5272039E1</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-41</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Paris 13 University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Research Unit on Nutritional Epidemiology, INSERM U557</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>E07F0648-A32B-4F86-AF24-234374039999</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-7</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>71E8DA8A-257A-43F0-93A0-ACD7BB0A6C54</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-13</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Istituto Auxologico Italiano</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Antithrombotic Treatment Trialists' (ATT) Collaboration</gtr:description><gtr:id>D7DF37F1-FC91-4692-91D5-DE39B83D5AAF</gtr:id><gtr:impact>Our 2009 Lancet publication (373: 1849-60) has been very highly cited (over 650 citations to date) , is widely incorporated into treatment guidelines worldwide, and resulted in the MHRA issuing a warning against aspirin use for primary prevention (http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087716).</gtr:impact><gtr:outcomeId>54183e7975cdb7.39916488-5</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating aspirin for the primary prevention of vascular disease. Data are now available on 95,000 patients in 6 trials.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>13B0757A-981A-46F7-9A2E-954D51830395</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-9</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sasaki Institute</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>12A9EECF-FF9C-476D-B1C5-F3BF3E9A0D2D</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-38</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bergen</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Global Public Health and Primary Care (IGS)</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>853F6F50-06C8-436C-BA43-E6CE5653E009</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-2</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Glasgow</gtr:department><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>1D439DFB-F5CC-4241-BC6D-B54319F88870</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-9</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McMaster University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>66B9E793-CBA5-4D6A-8DC8-5E03769395DD</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-3</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bergen</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Institute of Medicine</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>DF6F089B-72EA-409B-82BC-F88437631713</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-16</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine and Health Sciences</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>5B252795-2AC4-4546-9A09-5755211BC07A</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-9</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rikshospitalet , Sogsnsavvsveien</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>7F41B400-4590-4642-AE7E-51D9348425FC</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-44</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas Southwestern Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>5D9B26F4-06C6-44BE-935A-AC3DAB3A6880</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-21</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McMaster University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Population Health Research Institute</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>0A6294F2-B082-46E4-9AA9-6CEC45EA6AF2</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-7</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>0F371637-A2BB-4514-B2E1-30D031B88275</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-52</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cleveland Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>A29DCE46-BF95-41C7-ABAE-8FD112647204</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-20</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Haukeland University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Heart Disease</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>3E6E50D4-08A2-4B8D-A193-9E7AB3184EE4</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-2</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular and Clinical Medicine Edinburgh</gtr:department><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>C946E084-8E9C-49CE-A1FE-F9D550DF6AFB</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-11</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>23C4BB10-D7FC-4247-ACC7-9009413B863D</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-38</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mario Negri Institute for Pharmacological Research</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Consorzio Mario Negri Sud (CMNS)</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>143EEF34-93B6-4BF9-9CAC-A9BAF80D921A</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-15</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Unit? de Recherche en Epid?miologie Nutritionnelle (UREN), Sorbonne-Paris-Cit?, UMR Inserm, Paris, France</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>733F3091-7C90-4DB7-81D9-EBE4954DD7B3</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-9</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>20644F4F-8DC8-4CE4-81B6-A4BC9370CA9B</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-4</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals of Cleveland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>65897BB8-0EC0-44CB-8330-B3B51ECADC34</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-47</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>CC6BB284-4716-4507-A141-82013F4E4AD3</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-1</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Catholic University Medical School</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>7F472F45-988C-4D24-94D5-FB5D7DC22DBC</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-4</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Taiwan University</gtr:collaboratingOrganisation><gtr:country>Taiwan</gtr:country><gtr:department>Department of Pediatrics</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>30545D12-D0BC-474C-A7E8-8F6E835DBBB9</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-12</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Seoul National University</gtr:collaboratingOrganisation><gtr:country>Korea, Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>DBDAC89F-AB0E-4058-9C61-61BDBB998C28</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-40</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital, Josef-Schneider-Str 2, Germany</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Division of Nephrology</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>CF25B11B-1B51-4475-84F1-9A3C38DDEC48</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-20</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Cardiovascular Medicine</gtr:department><gtr:description>Antithrombotic Treatment Trialists' (ATT) Collaboration</gtr:description><gtr:id>4EDE2F19-1EB7-4ABF-AD64-E6A95B9AE9E7</gtr:id><gtr:impact>Our 2009 Lancet publication (373: 1849-60) has been very highly cited (over 650 citations to date) , is widely incorporated into treatment guidelines worldwide, and resulted in the MHRA issuing a warning against aspirin use for primary prevention (http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087716).</gtr:impact><gtr:outcomeId>54183e7975cdb7.39916488-1</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating aspirin for the primary prevention of vascular disease. Data are now available on 95,000 patients in 6 trials.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>138ACC1A-FA40-49C1-8B66-02F0EF5A2996</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-55</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>AF5753B8-11CF-4DA4-AB94-84F270EE847D</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-12</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stanford University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>1E65F27F-33AF-43BD-881F-1BC669640603</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-10</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mitsukoshi Health &amp; Welfare Foundation</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>4F26AD1E-DADF-4B8B-A820-50AC9D36AB98</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-55</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Institute for Translational Medicine and Therapeutics (ITMAT)</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>9D52A055-C5B0-4BD2-9081-A67999270423</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-7</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Linkoping University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>University Medical School Linkoping</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>478488AD-D5BF-4FE3-9002-C3840C176F55</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-50</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>F059FC90-2E1E-4C5D-9EF0-3E6B0A025C05</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-1</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hennepin County Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Clinical Epidemiology</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>AE5B402A-8A6D-4326-9406-CE32F5D8A5C3</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-41</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>E14B66D9-06DC-4441-8A8B-2717C0BE968D</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-64</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beijing Huilongguan Hospital</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>D314508E-C2BE-4CAB-A8F6-013E443C1CF5</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-52</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lyon</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>517A5282-60A2-4D09-92D4-1AC0F53360F7</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-34</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Louisville</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>4FF98329-9B79-4638-A034-41C2584B41E1</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-43</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>0BB27928-3EA0-415D-85FD-323CB8AFAE9B</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-1</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Alabama at Birmingham</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>CDD84766-4742-400F-B1C8-DAF7D1B4AA78</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-13</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Western Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>School of Medicine and Pharmacology</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>DF918BF5-DC2D-4EA5-9A17-DC2B8B3A2123</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-6</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mexican Social Security Insitute (IMSS)</gtr:collaboratingOrganisation><gtr:country>Mexico, United Mexican States</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>C18F67AA-8CFC-4987-AE4C-BFAD5946EB01</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-36</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Physical Therapy and Rehabilitation Science</gtr:department><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>A64D1A28-14CB-4283-9515-CBC2888D05E2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-5</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mario Negri Institute for Pharmacological Research</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>DD342198-2A65-4A1B-9BE8-354F4F17878B</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-10</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>American University of Beirut</gtr:collaboratingOrganisation><gtr:country>Lebanon, Lebanese Republic</gtr:country><gtr:department>Epidemiology and Population Health Department (EPHD)</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>252F75B0-CDFC-459A-992F-AB63548E61DE</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-2</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ottawa</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>E64883B9-316F-430C-84EA-8B0437A089A0</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-21</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Auckland City Hospital</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>5D835A31-517F-4047-A96C-A72AF26063E7</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-16</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>F84E70CE-20B5-4118-BC46-5AC48DC219EB</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-53</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Chieti-Pescara</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>A54E4DA8-4B57-47A0-810D-073ECFB120E4</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-46</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>72C8543C-4AB3-44BE-812E-99D299208636</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-25</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dresden</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>85FCEBFE-AB0D-4667-BE7B-E0EEDF32FCD4</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-14</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Northwestern University Chicago</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Feinberg School of Medicine</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>F0DA858E-6780-4ECB-8A45-6E0978A0708D</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-19</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Global R &amp; D</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>7E6C7ADD-B466-4B4A-AE98-B4999966812C</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-62</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Gothenburg</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Sahlgrenska Academy</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>11315F8F-A30E-486F-A0FB-49B4183A792C</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-4</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Georgetown University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>29096CA5-000A-4149-B02F-33FBA654087D</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-24</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>51C7DF02-E26A-4D5C-BDE7-E0C9C0473AB9</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-22</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Epidemiology</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>E587E5CD-BD58-4B67-97C6-29C2FD822ADC</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-14</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ecological Institute of Caspian Sea</gtr:collaboratingOrganisation><gtr:country>Iran, Islamic Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>64BA3AC9-3004-4291-A517-0D2111AD72DD</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-37</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Uppsala University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>4BE5B764-121C-4D11-8B90-EE19999E3597</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-51</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Florey Neurosciences Institute Melbourne Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>63FBD27E-420A-49D3-8BCC-7ADDF1F211CF</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-4</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>3172090E-EBD2-4EB0-90C3-7B7DA8B721BA</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-5</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ulleval University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>DDB8582C-1856-417F-BDE6-D160FDFD2C08</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-43</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>D50B6485-370F-46F8-9703-C4A3043451EC</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-4</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>315E18CD-F3B2-4AD4-8F58-CAC4C9DDF9CF</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-36</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Sydney Medical School</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>BCF4C202-0105-4D23-B33C-2DC78D9970BD</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-18</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>CC080F91-4969-4BFA-91C6-7A7E1BB3EE9A</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-17</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McMaster University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>98E16860-3F50-4360-B16B-2E485DDA8A19</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-3</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BC Children's Hospital</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Children's Heart Centre</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>6F946087-8B57-4EE2-B6FD-E7791FF73266</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-13</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Regeneron Pharmaceuticals, Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>96F89527-C088-4585-B399-148400137716</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-66</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Cerebral and Cardiovascular Centre</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>B4712ED8-904B-40EC-A097-D6EE3734356B</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-7</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>A4E3489D-A737-4AFC-85A2-E9FC4B8BF2CF</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-63</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>24896CEB-9C08-4A3A-8CF8-25523FB1090B</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-56</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St Mary's Hospital, London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>91B5F5CD-18A6-49D5-96A6-65EEC77A2E80</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-35</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wurzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>B11539D0-146F-4EAD-969D-A81F465976B4</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-59</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boehringer Ingelheim</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>191B1302-1799-4439-89A2-FD24A249807A</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-2</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nordic School of Public Health</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>D7F38CB3-2C02-439E-9075-E1A5B1D0CF9F</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-50</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MAM College of Pharmacology</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>5EFCCA3F-A673-4112-BAD6-ABFDCC6FCCC8</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-48</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Public Health Texas</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>79327B48-DDF8-45ED-9B5B-BD10B7B2AA9B</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-29</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical Gerontology</gtr:department><gtr:description>Antithrombotic Treatment Trialists' (ATT) Collaboration</gtr:description><gtr:id>F66102A0-A835-409F-BC76-B210C6BD7D1F</gtr:id><gtr:impact>Our 2009 Lancet publication (373: 1849-60) has been very highly cited (over 650 citations to date) , is widely incorporated into treatment guidelines worldwide, and resulted in the MHRA issuing a warning against aspirin use for primary prevention (http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087716).</gtr:impact><gtr:outcomeId>54183e7975cdb7.39916488-3</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating aspirin for the primary prevention of vascular disease. Data are now available on 95,000 patients in 6 trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>259728B3-A374-4397-B28F-3831DA867A79</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-19</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cedars-Sinai Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>45960B0F-3575-4FBA-9BE0-4F1FD194C379</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-1</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Endocrinology</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>B69B1B32-2E8C-4765-90A5-A3F79417B700</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-15</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>New England Research Institutes Watertown</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>1827B605-1A99-455D-97AA-75A8176EAC03</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-2</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tri-Services General Hospital</gtr:collaboratingOrganisation><gtr:country>Taiwan</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>095F156E-4D32-4B14-8CB5-B750EC2C7C94</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-30</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Maastricht University (UM)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>School for Public Health and Primary Care Maastricht</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>06E5DFE3-1647-4AB4-B531-1C9D5587369C</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-3</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rosalin Franklin University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Rosalin Franklin</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>A82D6019-6E06-414E-8C80-0FE5111FD6F4</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-31</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Nutrition and Public Health Intervention Research</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>07D504F9-F254-4B42-99E4-46CA27795D33</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-11</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tripler Medical Army Center, US</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>6D510721-6867-4715-A2A9-C34DF9F0A420</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-35</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Glasgow Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>D940C4A8-F12D-43F3-869F-42AD2B738A57</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-27</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cardiovascular Science</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>86BDCAD9-243D-4383-B289-FF92A8AD8EC4</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-10</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Russells Hall Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>2597BBAD-D7E6-4F79-AF09-EAA37067F90B</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-23</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Heart,?Lung, and?Blood Institute?(NHLBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>46C35B1F-6A3E-4279-827D-C0BFEDE1D727</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-12</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>1A36C5D4-6377-4125-9A2D-3C42DA3764F7</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-54</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stanford University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>EA0E1C63-B8E1-4A4C-BEE8-F1A65747D811</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-9</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>FCBB3A0B-58C2-45FE-8DB8-56D3A0EA781D</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-61</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vanderbilt University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vanderbilt Medical Center</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>737D0383-92AC-4917-8444-40A2CC2B1137</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-17</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>George Institute for Global Health</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>F00ED693-82C7-409F-A7DC-9329D0ACF1DD</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-8</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>VU University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>B2A12766-CFD9-4B08-931B-06D1DEF265B4</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-40</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gastrointestinal &amp; Other Cancers Research Group</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>66DD61EF-DFF8-481C-8A51-4F0F8879A7B0</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-49</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hamilton Health Sciences</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>EAD01D34-09C0-43D4-8F19-0FBD7DF85122</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-13</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Brompton Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical Trials and Evaluation Unit</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>370FA41F-AC02-4819-8E4D-EDEF7F2FFF44</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-8</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Taipei Veterans General Hospital</gtr:collaboratingOrganisation><gtr:country>Taiwan</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>BFEE00BF-8C1A-4E74-8570-3D3633A626FF</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-31</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>AFE1C726-0971-4103-9080-AB2A63D9F605</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-3</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>VA Boston Healthcare System</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC)</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>74BFC2F5-EEFB-4895-BAA6-125A93CB069B</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-10</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>37BF260D-C098-4CD0-9327-3A130CD80378</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-14</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>New York University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>1873A47A-74A2-4B42-A3A0-FE9793ECA759</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-6</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of North Norway</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Heart Disease</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>3A0550CD-1BF0-4239-9233-DB846A29E3CB</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-8</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fred Hutchinson Cancer Research Center (FHCRC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>36DC5969-41A9-4D2C-905C-716DACBCDDDA</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-53</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>788FFED5-9650-4ED6-979C-983B31B1D5E2</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-14</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>77B6A4FD-21E0-4484-9659-84584CF24785</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-12</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's Medical Centre</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>8BCBE05A-BFA8-4A7D-8B0D-475E3B314D41</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-5</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal London Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>7D0642CD-6E49-4EFF-A4DF-C43A499F2647</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-34</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>EA525AAC-8005-4DD6-A383-E1B4BBE4B125</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-12</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>0347E97D-6F3F-46FB-BB95-6A3A2730D3BF</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-2</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital of Psychiatry and Psychotherapy, Germany</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>2F99F990-ABA3-4C07-BF8C-39240C59D8FF</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-42</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Perth Hospital</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>365EE762-135B-4783-8D53-F46EECF48A4A</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-5</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cagliari</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>F8FC50F7-ED3B-40BD-A8DA-4352249EAA32</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-47</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Arizona</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>4E08BC5C-B737-4A2B-B9A9-375492B5C9AD</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-15</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ANMCO Research Centre</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>1B003FCA-3D0C-411D-AD48-96FC856E8B3E</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-3</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sapienza University of Rome</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>91215113-60F8-4504-88FB-EE2FF2BE0B1F</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-18</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Cancer Center</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>F25796B8-F730-40F2-9FF1-2A8541121C1A</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-8</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas Health Science Center San Antonio, BrainMap Database</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>2498A9DA-ACDC-493E-B941-297A505E1600</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-30</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wake Forest University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Wake Forest School of Medicine</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>DFE3D56E-D967-4037-AB94-36F326BE8360</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-58</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fondazione IRCCS Policlinico San Matteo</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>E56A1403-CA98-4920-9105-749207CFC2C7</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-7</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Otago</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Department of Human Nutrition</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>37B8002F-C980-4410-9E80-CC6F59B8D26D</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-1</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sheba Medical Centre</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>D9C002D3-2FBB-4AB2-95EE-844329372733</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-54</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Utah</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Utah</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>171FE128-6827-40BF-BD3D-4308A763A99D</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-32</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>New collaboration for MTT Collaboration</gtr:description><gtr:id>B6E9171E-1EE3-4629-B8A7-D94C2476284C</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e6f2d50cf5.97258973-1</gtr:outcomeId><gtr:partnerContribution>New collaboration for Marfan Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaboration for Marfan Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital Universitari Vall d'Hebron</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Department of Cardiology</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>4F229665-9512-4FB2-852D-0D128AAB4E8B</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-11</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Antwerp University Hospital</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Center for Medical Genetics</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>43EF17A9-9D06-4E39-AB63-D565F6A043D7</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-15</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>181F3D01-9398-4463-8AC5-CBD872220246</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-65</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>FCD9BD92-1BB1-44BA-87C4-3BFA72F363DE</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-56</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>E383461B-6DC2-4C0F-8ED8-80351B64666F</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-7</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pharma Clinical</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>4A478237-B4D2-418B-AF68-1B6126B9A200</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-5</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Icahn School of Medicine at Mount Sinai</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>132F3478-80F5-4E62-9030-D5D3F74292E8</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-10</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Gothenburg</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>963FF4EF-E6AF-4DC1-B155-94DC0BFA467E</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-8</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wageningen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Division of Human Nutrition</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>A44A42C7-0069-4555-ADCB-16AA68FF02CF</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-10</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Churchill Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>951B0C30-CB3A-4AD3-80F2-E3EEAF6B2BFA</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-48</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Commission on Human Medicines (CHM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Member of Commission on Human Medicine Expert Working Group</gtr:description><gtr:id>B8BCE1B2-2D43-44F9-A97C-429A72745BA2</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56d9b50ce92c53.56160773-1</gtr:outcomeId><gtr:partnerContribution>organising body</gtr:partnerContribution><gtr:piContribution>Member of the Expert Working Group</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>F6CF9331-403C-4EEE-A968-36CFC8F242C2</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-39</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Zagreb</gtr:collaboratingOrganisation><gtr:country>Croatia, Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>E9E2CF2F-7905-4C36-81EF-EC2E5B5F2E37</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-39</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Thrombosis Center of Buenos Aires</gtr:collaboratingOrganisation><gtr:country>Argentina, Argentine Republic</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>406D66B8-DAC7-4172-B5D4-C9345CE8858A</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-26</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Western University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Clinical Neurological Sciences</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>814CCDBF-F01A-4CDD-8553-343C51B0FA34</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-6</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>AE99757B-F413-4DEF-AD0E-12144EF92459</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-60</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tisch Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>FE8B785D-3958-41F8-BE12-D4FF924B87AD</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-1</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>8C08A3FE-9A9B-4812-BDD5-B8B5216969F7</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-33</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Maryland</gtr:department><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>63F989A5-2CAB-4FAF-9F94-1BF8AD2FE823</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-11</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>John Radcliffe Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>B903936C-1758-4E2C-AC24-DE7B7D924E58</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-49</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Florida Atlantic University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Charles E. Schmidt College of Science</gtr:department><gtr:description>Antithrombotic Treatment Trialists' (ATT) Collaboration</gtr:description><gtr:id>816E7D79-7339-4A0D-8FD0-25E578974133</gtr:id><gtr:impact>Our 2009 Lancet publication (373: 1849-60) has been very highly cited (over 650 citations to date) , is widely incorporated into treatment guidelines worldwide, and resulted in the MHRA issuing a warning against aspirin use for primary prevention (http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087716).</gtr:impact><gtr:outcomeId>54183e7975cdb7.39916488-2</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating aspirin for the primary prevention of vascular disease. Data are now available on 95,000 patients in 6 trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Statistics Collaborative</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>3C2620BF-85C8-466A-9FAD-FAE56B476F9E</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-22</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of the United States of America</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>United States Department of Veterans Affairs</gtr:department><gtr:description>B-Vitamins Cancer Collaboration</gtr:description><gtr:id>662F1139-D2A6-4F5B-9B54-2BEA71489BB9</gtr:id><gtr:impact>This collaboration has clearly demonstrated the lack of effect of folic acid on vascular outcomes (2010, Archives of Internal Medicine; 170: 1622-31), or cancer incidence (2013, Lancet 381: 23-9).</gtr:impact><gtr:outcomeId>542e72c2aefc78.74344194-11</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ogun State University Teaching Hospital (OSUTH)</gtr:collaboratingOrganisation><gtr:country>Nigeria, Federal Republic of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>09644B1F-D897-447F-8C8E-F8EEAF928055</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-23</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>U.S. Department of Veteran Affairs</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>3A37AAE8-61DE-4C35-9BFA-08322E932604</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-9</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>State University of New York</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>52AA208A-E582-4DF8-81AB-D2A43E75AD94</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-46</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cardiovascular and Medical Sciences (ICAMS)</gtr:department><gtr:description>B-Vitamins Cognitive Function Collaboration</gtr:description><gtr:id>C3019E3C-5EF9-4F17-9F63-5E62B70F78A5</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e6acddc8447.69786798-5</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual level patient data from their randomised trials.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collaboration which has brought together the individual patient data from randomised trials of folic acid supplementation in individuals at increased risk of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>23A32AD1-5D1B-4486-B64A-DCC194BF840C</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-29</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rush University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>A0327D5D-E9EE-416C-A3F5-D99755DADD2E</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-27</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sahlgrenska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>4445A134-69D0-4803-8B55-356BE185564B</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-7</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>CDD0FE72-11A8-4C08-9C4A-45D089F9976B</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-5</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>BFADA82A-DF1E-4FD9-B428-577C57306922</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-57</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>New collaborations for Gastroprotectant Treatment Trialists' Collaboration</gtr:description><gtr:id>B426997D-BA23-4DAC-8331-76E6A0074FE2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58b7e65ebdfbf9.84803122-8</gtr:outcomeId><gtr:partnerContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:partnerContribution><gtr:piContribution>New collaborations on the Gastroprotectant Treatment Trialists' Collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jacksonville Centre for Clinical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>47C7D69C-2D72-4FC1-B902-F2BE6C5AC27D</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-24</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>H?pital Bichat-Claude Bernard</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>French National Reference Centre for Marfan Syndrome</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>C1343A3F-2683-4106-8298-C70A46D4037E</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-16</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Toronto General Hospital</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>EE4ABC38-904D-4FA9-94CD-73E02670188B</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-3</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>EDCEABBF-776D-43DE-9842-DF1EE03D699D</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-33</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Heart,?Lung, and?Blood Institute?(NHLBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>987C3D2A-04C6-4D62-9E86-9D5738CC24CA</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-4</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>A9EF3BDA-8EB3-42F3-9A1B-31D299D3CDB0</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-51</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King Fahd Hospital, Saudi Arabia</gtr:collaboratingOrganisation><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:description>Coxib and traditional NSAID Treatment (CNT) Collaboration</gtr:description><gtr:id>93004078-204C-4D49-942D-D4B3D7D77CE0</gtr:id><gtr:impact>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors as a result of reviewing the new evidence from our meta-analysis.</gtr:impact><gtr:outcomeId>54184621c13541.74945130-25</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials evaluating coxibs and traditional NSAIDs.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>NHMRC Clinical Trials Centre</gtr:department><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>DD45C495-616A-4BE4-8639-5F893930EB92</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-45</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sahlgrenska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>F77EF5F3-A23D-4821-A81F-691638309274</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-28</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Iowa</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>7BF8FE04-19C3-462F-8A33-2554392D219B</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-32</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sheba Medical Centre</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:description><gtr:id>BC980EFE-C89D-4E4E-9C2C-5FA588C47223</gtr:id><gtr:impact>The results of the collaboration have had a major influence on lipid-lowering treatment guidelines worldwide</gtr:impact><gtr:outcomeId>5417ff8c5208b6.32019077-2</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own LDL-lowering trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from all large-scale trials of LDL-lowering therapy. Data are now available on 190,000 patients in 29 trials and the CTT has published 4 major papers (over 950 citations to date) in the past 5 years.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ghent</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Centre for Medical Genetics</gtr:department><gtr:description>The Marfan Treatment Trialists' Collaboration</gtr:description><gtr:id>8891D113-4484-4C87-95A3-AF70EC9C1A6E</gtr:id><gtr:impact>None.</gtr:impact><gtr:outcomeId>542e769a0f8cf8.62505902-6</gtr:outcomeId><gtr:partnerContribution>Individual collaborators will provide individual patient data for meta-analysis according to a recently finalised protocol and statistical analysis plan.</gtr:partnerContribution><gtr:piContribution>The collaboration was created in 2012 with the Department of Cardiovascular Medicine, Oxford and will bring together the individual patient data from all randomised trials of angiotensin receptor antagonists/blockers (ARBs) in Marfan syndrome.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helsinki University Central Hospital</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Stroke Thrombolysis Trialists' (STT) Collaboration</gtr:description><gtr:id>60A34A4D-75A7-472D-9968-3144E5704AB6</gtr:id><gtr:impact>Recent Lancet paper (2014: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960584-5/fulltext) results of meta-analysis clearly showed that alteplase given promptly after stroke reduces long-term disability.</gtr:impact><gtr:outcomeId>541a94bb04af41.25799956-6</gtr:outcomeId><gtr:partnerContribution>Collaborators provide individual participant data and other supporting information from their own trials and through the regular meetings of the collaboration provide input to the questions to be addressed, preparation of analysis plans and discussion of results.</gtr:partnerContribution><gtr:piContribution>CTSU coordinates the collection and analysis of individual participant data from of all eligible and available trials of thrombolysis with rt-PA after acute ischaemic stroke.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Merits of more intensive use of statins: Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2333092D-2047-4C05-B251-8B9661DA25FE</gtr:id><gtr:impact>Press release resulted in the following media coverage:

More potent statins 'could save thousands every year': The Daily Telegraph, p. 1, 09/11/10 http://www.telegraph.co.uk/health/8117635/More-potent-statins-could-save-thousands.html
New wonder statin 'could save thousands' at risk of heart attacks or strokes: Daily Mail, 09/11/2010
http://www.dailymail.co.uk/health/article-1327943/New-wonder-statin-save-thousands-risk-heart-attacks-strokes.html?ito=feeds-newsxml
Statin is new wonder drug: Daily Express, p. 1, 09/11/10
http://www.dailyexpress.co.uk/posts/view/210424
Aggressive use of statins further cuts cardio risk: study: Independent, 10/11/10
http://www.independent.co.uk/life-style/health-and-families/aggressive-use-of-statins-further-cuts-cardio-risk-study-2129947.html
Stronger statins 'could save lives': Daily Mirror, 09/11/10
http://www.mirror.co.uk/news/latest/2010/11/09/stronger-statins-could-save-lives-115875-22703591/
Statin increase 'will save lives': BBC News Online, 09/11/2010
http://www.bbc.co.uk/news/health-11712569
Higher Dose Statins Could Save Lives: Sky News Online, 09/11/2010
http://news.sky.com/skynews/Home/UK-News/Higher-Dose-Statins-Could-Save-Lives-According-To-Report-By-UK-And-Australian-Scientists/Article/201011215797761?lpos=UK_News_First_Home_Page_Feature_Teaser_Region_0&amp;amp;lid=ARTICLE_15797761_Higher_Dose_Statins_Could_Save_Lives_According_To_Report_By_UK_And_Australian_Scientists
Aggressive statins use cuts heart risk: Sydney Morning Herald, 09/11/10
http://news.smh.com.au/breaking-news-world/aggressive-statins-use-cuts-heart-risk-20101109-17l1q.html
Higher Statin Doses Linked to Fewer Heart Attacks, Stroke: US News &amp;amp; World Report, HealthDay blog, 09/11/10
http://health.usnews.com/health-news/diet-fitness/heart/articles/2010/11/09/higher-statin-doses-linked-to-fewer-heart-attacks-stroke.html
Aggressive use of statins further cuts cardio risk: Star (Malaysia), p. 38, 10/11/10
Radio: BBC Radio 5 Up all night, 09/11/10, 01:51am; BBC Radio Oxford, 09/11/10, 11.48am
http://www.bbc.co.uk/iplayer/episode/p00by2cc/Louisa_Hannan_09_11_2010/


To highlight amongst doctors and patients the benefits of more intensive cholesterol lowering with statins.</gtr:impact><gtr:outcomeId>5433e214b9e4b9.44450986</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Abingdon ATOM science festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>67683AFE-AD01-4509-A77C-BA25F3D786C3</gtr:id><gtr:impact>Gave a lecture about my owrk: Treatment of vascular disease; preventing heart disease and strokes</gtr:impact><gtr:outcomeId>56d9b3412019a4.71538379</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Merits of considering more extensive use of statins: Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FB7B70C8-40C0-4C64-BF39-D72F1772C72B</gtr:id><gtr:impact>Press release resulted in following media coverage: 

Give statins to all over-50s: Daily Mail, p. 1, 29/08/12 http://www.dailymail.co.uk/health/article-2194892/All-50s-statins-regardless-health-history-says-Oxford-professor.html
Statins fear is 'putting patient's health at risk', researchers say: Daily Telegraph, p. 1, 29/08/12
http://www.telegraph.co.uk/health/healthnews/9504753/Statins-fear-is-putting-patients-health-at-risk-researchers-say.html
Heart drugs for all over-50s call: Daily Mirror, p. 16, 29/08/12
Give cholesterol-busting statins to all over-50s: Daily Express, p. 11, 29/08/12
http://www.express.co.uk/posts/view/342728/-Cholesterol-busting-statins-should-be-given-to-ALL-over-50s- 
Statin 'for everyone over 50': The Sun, p. 20, 29/08/12
Oxford professor re-ignites statins row: The Times online, 29/08/12
http://www.thetimes.co.uk/tto/health/news/article3521615.ece
Health expert says statins should be taken by everyone over 50, even the healthy: 
The Herald Sun online (Australia), 29/08/12
http://www.heraldsun.com.au/news/national/health-expert-says-statins-should-be-taken-by-everyone-over-50-even-the-healthy/story-fndo471r-1226461088762
TV: ITV 1 Daybreak: 29/08/12, 06:05; BBC News: 28/08/12, 23:27; ITV 1 South Meridian Tonight: 29/08/12, 6.08pm; BBC News Channel: 29/08/12, 11.27pm
Radio: BBC Radio Wales Good Morning Wales: 29/08/12, 06:18; BBC Radio Northampton: 29/08/12, 06:13; BBC Radio Foyle: 29/08/12, 1.56pm; BBC Radio Leeds: 29/08/12, 10.36am


To highlight to doctors and the public the merits of more extensive use of statins.</gtr:impact><gtr:outcomeId>5433e664d31c55.64350671</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media coverage</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B363783D-0E24-4EED-BC75-BC621521A2D4</gtr:id><gtr:impact>Media exposure as a result of the scientific paper published that examined the benefits of statins to women. Coverage was international and included Reuters, Science Daily, Medscape and national newspapers.</gtr:impact><gtr:outcomeId>56d9b5f3613349.67405504</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release: Common painkillers increase heart attack risk</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E1001097-AD07-489A-98EB-5D379A4E217A</gtr:id><gtr:impact>Media coverage:

http://www.wired-gov.net/wg/wg-news-1.nsf/0/2993B5F1662159E780257B7C0043B5D0?OpenDocument
http://www.pharmatimes.com/Article/13-05-31/Long_term_painkiller_use_linked_to_heart_risk.aspx
http://www.bbc.co.uk/mundo/noticias/2013/05/130530_salud_analgesico_riesgo_gtg.shtml
http://www.midsussextimes.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.harboroughmail.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.bournelocal.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.louthleader.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.fenlandcitizen.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.cotswoldjournal.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.bucksherald.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.wscountytimes.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.tringtoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.leightonbuzzardonline.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.westsussextoday.co.uk/news/regional/study-in-painkiller-dosage-warning-1-5143606
http://www.biggleswadetoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.thametoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.granthamjournal.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.rugbyadvertiser.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.bostonstandard.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.haylingtoday.co.uk/news/regional/study-in-painkiller-dosage-warning-1-5143606
http://www.lutterworthmail.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.thisischeshire.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.witneygazette.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.meltontimes.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.herefordtimes.com/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.hemeltoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.hastingsobserver.co.uk/news/regional-news/study-in-painkiller-dosage-warning-1-5143606
http://www.lynnnews.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.confused.com/health-insurance/news/study-in-painkiller-dosage-warning-2571
http://www.bognor.co.uk/news/regional/study-in-painkiller-dosage-warning-1-5143606
http://www.dissexpress.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.lutontoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.yorkpress.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.kenilworthweeklynews.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.banburyguardian.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.portsmouth.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.suffolkfreepress.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.dunstabletoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.wandsworthguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.burytimes.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.eastbourneherald.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.dudleynews.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.miltonkeynes.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.leamingtoncourier.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.buryfreepress.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.sleafordstandard.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.buckinghamtoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.marketrasenmail.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.crawleyobserver.co.uk/news/regional/study-in-painkiller-dosage-warning-1-5143606
http://www.rutland-times.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.cravenherald.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.skegnessstandard.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.droitwichadvertiser.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.bedfordtoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.newmarketjournal.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.congletonguardian.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.daventryexpress.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.hillingdontimes.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.peterboroughtoday.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.borehamwoodtimes.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.petersfieldpost.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.horncastlenews.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.warwickcourier.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.ealingtimes.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.thelancasterandmorecambecitizen.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.hertfordshiremercury.co.uk/Hertfordshire/National-News/Study-in-painkiller-dosage-warning-2-7455347.xnf
http://www.haverhillecho.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.spaldingtoday.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.ellesmereportpioneer.co.uk/ellesmere-port-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-55940-33403855/
http://icburton.icnetwork.co.uk/news/natnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403719%26siteid=82449-name_page.html
http://www.formbytimes.co.uk/news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-66401-33403807/
http://www.bedfordshire-news.co.uk/News/UK-and-world-news/Study-in-painkiller-dosage-warning-1-7455347.xnf
http://www.falmouthpacket.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.harlowstar.co.uk/News/National-News/Study-in-painkiller-dosage-warning-1-7455347.xnf
http://icwalsall.icnetwork.co.uk/news/natnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403839%26siteid=60240-name_page.html
http://www.theadvertisergroup.co.uk/Daily-News/National-News/Study-in-painkiller-dosage-warning-2-7455347.xnf
http://www.solihullnews.net/news/uk-news/2013/05/30/study-in-painkiller-dosage-warning-105074-33403583/
http://www.littlehamptongazette.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.northamptonchron.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.crewechronicle.co.uk/crewe-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-96135-33403631/
http://www.chichester.co.uk/news/national/study-in-painkiller-dosage-warning-1-5143422
http://www.southportvisiter.co.uk/southport-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-101022-33403599/
http://www.runcornandwidnesweeklynews.co.uk/runcorn-widnes-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-55368-33403863/
http://www.hertsandessexobserver.co.uk/News/National-News/Study-in-painkiller-dosage-warning-2-7455347.xnf
http://www.wirralnews.co.uk/wirral-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-80491-33403759/
http://www.harrowobserver.co.uk/west-london-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-116451-33403503/
http://icsuttoncoldfield.icnetwork.co.uk/news/natnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403887%26siteid=52630-name_page.html
http://www.osadvertiser.co.uk/news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-80904-33403743/
http://www.uxbridgegazette.co.uk/west-london-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-113046-33403527/
http://icwolverhampton.icnetwork.co.uk/news/natnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403639%26siteid=94950-name_page.html
http://www.crosbyherald.co.uk/news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-68459-33403791/
http://www.examiner.co.uk/news/national-news/2013/05/30/study-in-painkiller-dosage-warning-86081-33403703/
http://www.fulhamchronicle.co.uk/fulham-and-hammersmith-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-82029-33403735/
http://www.chesterchronicle.co.uk/chester-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-59067-33403847/
http://www.enfieldindependent.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.ealinggazette.co.uk/ealing-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-64767-33403815/
http://www.blackburncitizen.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.mkweb.co.uk/News/UK-and-World-News/Study-in-painkiller-dosage-warning-2-7455347.xnf
http://www.liverpooldailypost.co.uk/liverpool-news/uk-world-news/2013/05/30/study-in-painkiller-dosage-warning-99623-33403607/
http://iccheshireonline.icnetwork.co.uk/0100news/0300nationalnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403927%26siteid=50020-name_page.html
http://www.buckinghamshireadvertiser.co.uk/south-buckinghamshire-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-82398-33403727/
http://www.loughboroughecho.net/news/national-news/2013/05/30/study-in-painkiller-dosage-warning-73871-33403783/
http://www.talktalk.co.uk/news/uk/article/study-in-painkiller-dosage-warning/89834/
http://www.standard.co.uk/panewsfeeds/study-in-painkiller-dosage-warning-8636891.html
http://www.buckinghamshireexaminer.co.uk/south-bucks-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-114018-33403511/
http://www.chelmsfordweeklynews.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.express.co.uk/news/uk/403637/Study-in-painkiller-dosage-warning
http://icsolihull.icnetwork.co.uk/news/national/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403663%26siteid=91411-name_page.html
http://www.belfasttelegraph.co.uk/news/local-national/uk/study-in-painkiller-dosage-warning-29307237.html
http://www.yeovilexpress.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.romseyadvertiser.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.thurrockgazette.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.durhamtimes.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.thisishampshire.net/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.malverngazette.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.brentwoodweeklynews.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.kidderminstershuttle.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.creweguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.watfordobserver.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.southwalesargus.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.thewestmorlandgazette.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.thisisoxfordshire.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.barryanddistrictnews.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.banburycake.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.chorleycitizen.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.gazetteandherald.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.southendstandard.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.stalbansreview.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.newsshopper.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.wirralglobe.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.winsfordguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.middlewichguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.thisislocallondon.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.thenorthernecho.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.ludlowadvertiser.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.boatingcornwall.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.prestoncitizen.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/?ref=nt
http://www.eveshamjournal.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.businessdorset.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.northwichguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.sthelensstar.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.dailyecho.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.westerntelegraph.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.southwestfarmer.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.kingstonguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.heraldseries.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/?ref=nt
http://www.thisislancashire.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.wiltsglosstandard.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.walesfarmer.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.maldonandburnhamstandard.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.theboltonnews.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.wiltshirebusinessonline.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.bridportnews.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.bournemouthecho.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.somersetcountygazette.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.lancashiretelegraph.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.thisisthewestcountry.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.gazetteherald.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.croydonguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.stourbridgenews.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.theargus.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.oxfordmail.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.harrowtimes.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.basingstokegazette.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.bridgwatermercury.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.burnleycitizen.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.warringtonguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.leighjournal.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.oxfordtimes.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.messengernewspapers.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.salisburyjournal.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.knutsfordguardian.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.campaignseries.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.prestwichandwhitefieldguide.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.times-series.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.haringeyindependent.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.ledburyreporter.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.echo-news.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.harwichandmanningtreestandard.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.thisiswiltshire.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.guardian-series.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.stroudnewsandjournal.co.uk/uk_national_news/10451280.Study_in_painkiller_dosage_warning/
http://www.hampshirechronicle.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.basildonrecorder.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://news.uk.msn.com/uk/study-in-painkiller-dosage-warning
http://ictamworth.icnetwork.co.uk/news/natnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403687%26siteid=86764-name_page.html
http://iclichfield.icnetwork.co.uk/news/natnews/tm_headline=study-in-painkiller-dosage-warning%26method=full%26objectid=33403543%26siteid=108911-name_page.html
http://www.shropshirestar.com/news/uk-news/2013/05/30/study-in-painkiller-dosage-warning/
http://www.expressandstar.com/news/uk-news/2013/05/30/study-in-painkiller-dosage-warning/
http://www.hounslowchronicle.co.uk/west-london-news/world-uk-news/2013/05/30/study-in-painkiller-dosage-warning-109642-33403535/
http://www.hinckleytimes.net/news-in-hinckley/uk-news/2013/05/30/study-in-painkiller-dosage-warning-105367-33403575/
http://www.thisisguernsey.com/news/uk-news/2013/05/30/study-in-painkiller-dosage-warning/
http://www.thisisjersey.com/news/uk-news/2013/05/30/study-in-painkiller-dosage-warning/
http://www.stamfordmercury.co.uk/news/national-news/study-in-painkiller-dosage-warning-1-5143422
http://www.sussexexpress.co.uk/news/regional/study-in-painkiller-dosage-warning-1-5143606
http://www.pulsetoday.co.uk/clinical/therapy-areas/pain-relief/consider-switch-to-naproxen-in-arthritis-patients-gps-urged/20003119.article
http://www.halesowennews.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.independent.co.uk/life-style/health-and-families/health-news/study-links-common-painkillers-ibuprofen-and-diclofenac-to-increased-risk-of-heart-attack-8636745.html
http://www.ageuk.org.uk/latest-news/painkillers-linked-to-heart-disease/
http://www.gponline.com/News/article/1184344/common-painkillers-raise-heart-risks/
http://www.netdoctor.co.uk/interactive/news/common-painkillers-linked-to-heart-attack-risk-id801591952-t116.html
http://www.independent.co.uk/life-style/health-and-families/health-news/study-links-overthecounter-painkillers-to-increased-risk-of-heart-attack-8636745.html
http://www.medicalnewstoday.com/articles/261183.php
http://www.bioportfolio.com/news/article/1483535/Painkillers-Slightly-Increase-Heart-Risk.html
http://www.arthritisresearchuk.org/news/general-news/2013/may/some-nsaids-linked-to-small-but-significant-increase-in-heart-attack-risk.aspx
http://www.bioportfolio.com/news/article/1483943/Some-NSAIDs-linked-to-small-but-significant-increase-in-heart-attack-risk.html
http://www.noodls.com/viewNoodl/18803229/university-of-oxford-/small-increase-in-heart-risk-from-common-painkillers
http://www.ox.ac.uk/media/news_stories/2013/130530.html
http://www.express.co.uk/news/health/403652/Most-arthritis-victims-need-not-worry-about-painkiller-risks
http://www.guardian.co.uk/science/2013/may/30/painkillers-heart-attack-risk-study
http://www.pharmaceutical-int.com/news/painkillers-found-to-increase-heart-problems.html
http://www.bbc.co.uk/news/health-22713613
http://www.bbc.co.uk/indonesia/majalah/2013/05/130529_iptek_obat_jantung.shtml
http://www.dailystar.co.uk/latestnews/view/317404/Study-in-painkiller-dosage-warning/
http://www.heraldscotland.com/news/health/painkiller-use-linked-to-bigger-risk-of-heart-attack.21212962
http://www.wiltshiretimes.co.uk/news/national/news/10451280.Study_in_painkiller_dosage_warning/
http://www.itv.com/news/update/2013-05-30/professor-risks-are-relative-to-medical-background/
http://www.huffingtonpost.co.uk/2013/05/30/health-high-doses-painkillers-heart-risk_n_3356911.html
http://www.dailymail.co.uk/health/article-2333067/Painkillers-taken-millions-increase-heart-risk-Prolonged-use-leads-significant-danger.html?ico=home%5Eheadlines
http://www.mailonsunday.co.uk/health/article-2333067/Painkillers-taken-millions-increase-heart-risk-Prolonged-use-leads-significant-danger.html
http://www.manchesterwired.co.uk/news.php/1486945-Common-painkillers-pose-heart-risk
http://www.ukwirednews.com/news.php/1486945-Common-painkillers-pose-heart-risk
http://www.bbc.co.uk/news/health-22694858
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61128-9/fulltext
http://uk.reuters.com/article/2013/05/29/us-painkillers-risks-idUKBRE94S1FV20130529
http://www.yorkshirepost.co.uk/news/at-a-glance/general-news/high-painkiller-doses-found-to-raise-risk-of-heart-attack-or-stroke-1-5721318
http://metro.co.uk/2013/05/30/painkillers-may-increase-risk-of-heart-attacks-strokes-and-death-3817327/
http://www.independent.co.uk/life-style/health-and-families/health-news/study-links-painkillers-to-increased-risk-of-heart-attack-8636745.html
http://www.express.co.uk/news/health/403581/Heart-risks-for-high-dose-users-of-painkillers
http://www.express.co.uk/news/health/403576/Why-Ibuprofen-report-is-good-news
http://source.meltwaternews.com/tt/ft.com_all/article.php?which=20130529_780_5303
http://www.telegraph.co.uk/health/healthnews/10087871/Painkiller-taken-for-arthritis-is-heart-risk.html
http://medicalxpress.com/news/2013-05-meta-analysis-common-painkillers-heart-problems.html


Increased public awareness of the hazards of common painkillers.</gtr:impact><gtr:outcomeId>54491829235e08.02071456</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Society of Cardiology</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6212F88A-F92F-47C1-9941-04741CBCE1EC</gtr:id><gtr:impact>The European Society of Cardiology Congress for 2016, held in Rome</gtr:impact><gtr:outcomeId>58b7e0d6e5f089.68731333</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.eurolink-tours.com/2016/esc/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre press briefing re: statins</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E924D852-FF87-4617-B99B-6A711AC57CF4</gtr:id><gtr:impact>This was a media briefing to national and international press organisations on the Lancet paper 'Interpretation of the evidence for the efficacy and safety of statin therapy'. It tokk place on 28 June 2016</gtr:impact><gtr:outcomeId>58b7e7e29a56d1.72668011</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.sciencemediacentre.org/the-perception-of-statins-and-the-impact-of-intense-debate-on-statin-use/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release: Meta-analysis shows that alteplase given promptly after stroke reduces long-term disability</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8FE4592A-7E8B-4F1C-B08E-9E259639E98B</gtr:id><gtr:impact>Media coverage:

http://www.femtomedicine.com/prompt-administration-of-alteplase-treatment-reduces-disability-in-stroke-patients/
http://www.femtomedicine.com/alteplase-given-promptly-after-stroke-reduces-long-term-disability-even-in-older-people-those-with-severe-stroke/
http://www.femtomedicine.com/the-lancet-meta-analysis-shows-that-alteplase-given-promptly-after-stroke/
http://www.hospitaldr.co.uk/blogs/our-news/centralising-stroke-services-can-cut-deaths
http://medicalxpress.com/news/2014-08-meta-analysis-alteplase-promptly-long-term-disability.html
http://www.medicalnewstoday.com/releases/280587.php
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60584-5/fulltext



None.</gtr:impact><gtr:outcomeId>544912f7c0a374.33619184</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>No benefit from lowering homocysteine: Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>71925E75-B3C8-4C3B-870F-D4E5D3030C44</gtr:id><gtr:impact>Press release resulted in following media coverage: 

Regimens: Lower Homocysteine and Heart Risk: New York Times online, 28/06/10 http://www.nytimes.com/2010/06/29/health/research/29regi.html?scp=1&amp;amp;sq=jane%20armitage&amp;amp;st=cse
More Evidence That B Vitamins Alone Won't Counter Heart Risks: BusinessWeek, 22/06/2010?
Study: Folic Acid, B12 Don't Lower Heart Disease Risks: TIME, 22/06/2010?
http://www.time.com/time/health/article/0,8599,1998885,00.html?xid=rss-topstories
Study: Folic Acid Doesn't Cut Heart-Attack Risk: Newsweek, 22/06/2010?
http://www.newsweek.com/2010/06/22/observe-and-report.html
SEARCH published: No CV benefit on reducing homocysteine: TheHeart.Org, 22/06/2010?
Is new gene analysis the final chapter in the homocysteine saga? TheHeart.org, 21/02/2012
More Doubt on Link Between a Blood Chemical and Heart Disease: MSN Health (USA, via HealthDay newswire), 21/02/2012
More Doubt on Link Between a Blood Chemical and Heart Disease: DoctorsLounge (USA, via HealthDay newswire), 21/02/2012
http://www.doctorslounge.com/index.php/news/hd/26930


To clearly demonstrate to doctors and patients that homocysteine was not effective in reducing heart disease risk.</gtr:impact><gtr:outcomeId>5433e7840ccd34.97277772</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Aspirin risks outweigh vascular benefits in healthy: Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C51A5F5A-504F-4273-8651-BEA7C955C98C</gtr:id><gtr:impact>Press release resulted in following media coverage: 

An aspirin a day can do more harm than good: Daily Mail, p.39, 29/05/2009 http://www.dailymail.co.uk/health/article-1189355/An-aspirin-day-harm-good.html
Aspirin can put patients at risk: Daily Express, p.9, 29/05/2009
http://www.express.co.uk/posts/view/104077/Aspirin-can-put-patients-at-risk
Routine aspirin benefits queried: BBC News Online, 29/05/2009
Do the potential side-effects make aspirin a bitter pill to swallow?: The Times, p.11, 01/06/2009


To highlight to patients and doctors the risks of aspirin in healthy people.</gtr:impact><gtr:outcomeId>5433e3c4ee1093.32655300</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Engagement with Green Templeton College medical students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6C0E6C07-0159-411C-8063-25E0BA4BBC86</gtr:id><gtr:impact>Presentation about meta-analyses conducted at CTSU</gtr:impact><gtr:outcomeId>58b7e9b7208812.72490448</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre expert reaction briefing re: statins</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C1B9BFDB-C54F-4FF4-B0BE-3E594F7B9A79</gtr:id><gtr:impact>SMC expert reaction briefing to the Lancet paper interpreting the evidence on risk and benefits of statins on 8 September 2016</gtr:impact><gtr:outcomeId>58b7e890510df5.83379484</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.sciencemediacentre.org/interpreting-the-evidence--on-the-risks-and-benefits-of-statins/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Benefits and safety of statins in lower-risk people: Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D968031-1F46-4A78-940C-4A1FF01B9C4E</gtr:id><gtr:impact>Press release resulted in following media coverage: 

Statins for all over-50s to reduce heart deaths: The Daily Telegraph, front page, 17/05/12 http://www.telegraph.co.uk/health/healthnews/9269027/All-over-50s-should-be-taking-statins.html
Why everyone over 50 needs to be taking statins: Daily Mail, p. 3, 17/05/12
http://www.dailymail.co.uk/health/article-2145558/Why-EVERYONE-50-needs-taking-statins-Cholesterol-busting-pills-cut-risk-heart-attack-stroke.html?ito=feeds-newsxml
Statin drugs 'can benefit all the over-50s': The Times online, 17/05/12
http://www.thetimes.co.uk/tto/science/medicine/article3417234.ece
'Give statins to everyone over 50': Daily Express, p. 7, 17/05/12
http://www.express.co.uk/posts/view/320619/Give-statins-to-everyone-over-50
Up to 20m people should be prescribed statins, study says: The Guardian, p. 6, 17/05/12
http://www.guardian.co.uk/society/2012/may/17/statins-benefit-millions-heart-health?newsfeed=true
Statins 'could benefit the healthy': The Independent, 17/05/12
http://www.independent.co.uk/life-style/health-and-families/health-news/statins-could-benefit-the-healthy-7762347.html
Blanket protection: The Sunday Times, 'Briefing', p. 20, 20/05/12
http://www.thesundaytimes.co.uk/sto/comment/regulars/briefing/article1041917.eceStatin therapy may even benefit healthy - study: Channel 4 news online, 17/05/12
http://www.channel4.com/news/statin-therapy-may-even-benefit-healthy-study
Statins advised for over 50s: Sky News online, 17/05/12
http://news.sky.com/home/article/16229656
Guideline for statin therapy 'should be reconsidered': ITV News online, 17/05/12
http://www.itv.com/news/update/2012-05-17/guideline-for-statin-therapy-should-be-reconsidered/
Should people with a low risk of heart disease take statins? The Week, 17/05/2012
http://www.theweek.co.uk/health-science/46978/should-people-low-risk-heart-disease-take-statins#ixzz1vCtkclpv
Help for hearts: Oxford Mail, In Brief, p.5, 18/05/2012
Statins 'may even help healthy over-50s': NHS Choices website, 17/05/2012
http://www.nhs.uk/news/2012/05may/Pages/statins-may-help-for-healthy-middle-aged-adults.aspx
'Everyone above 50 must take statins regularly': Times of India online, via PTI, 18/05/2012
http://timesofindia.indiatimes.com/home/science/Everyone-above-50-must-take-statins-regularly/articleshow/13240272.cms
'Everyone above 50 should take statins regularly': Financial Express (India), 17/05/2012
http://www.financialexpress.com/news/everyone-over-50-years-should-take-statins-regularly/950659/
All over 50s should be taking statins to avoid heart attack: Newstrack India (via ANI), Unattributed, 17/05/12
http://www.newstrackindia.com/newsdetails/2012/05/17/96-All-over-50s-should-be-taking-statins-to-avoid-heart-attack.html
Statins could benefit health of millions: Gulf Times (Qatar), 17/05/2012
Statins 'could benefit the healthy': Kuwait News Agency, Unattributed, 17/05/12
http://www.kuna.net.kw/ArticleDetails.aspx?id=2241098?uage=en
BBC News online: NHS 'should consider giving statins to healthy people': 17/05/12
http://www.bbc.co.uk/news/health-18091708
Statins 'could save a lot of lives':
Daily Telegraph online (with ITN productions), 17/05/12. Online video report: Jeremy Pearson from the British Heart Foundation discusses the Oxford findings and their implications.
http://www.telegraph.co.uk/health/healthnews/9272279/Statins-could-save-a-lot-of-lives.html
Radio: BBC Radio 4 Today Programme: 17/05/12, 07:53
http://news.bbc.co.uk/today/hi/today/newsid_9721000/9721511.stm
Radio: BBC World Service Newshour: 17/05/2012, 14:19; BBC Radio 2: 17/05/12, 05:18; BBC London: 17/05/2012, 08:19, 10.02; BBC Radio Oxford: 17/05/2012, 14:01; BBC Radio West Midlands: 17/05/2012, 13:14; BBC Radio Sheffield: 17/05/2012, 07:03; BBC Radio Somerset: 17/05/12, 05:51; LBC 97.3: 17/05/12, 03:23, 07.23, 08:57; 
TV: Sky News Press Preview: 16/05/12, 21:51, 22:43; Sky News: 18/05/12, 00:39 


To highlight to patients and doctors the benefits and risks of statins in lower-risk people.</gtr:impact><gtr:outcomeId>5433e51b27c7c0.93553494</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>American Heart Association Science Symposium</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3123805E-3AB7-4E8D-AA4F-F17A0ADC556B</gtr:id><gtr:impact>The American Heart Association annual scientific meeting</gtr:impact><gtr:outcomeId>58b7e2287834f4.29380842</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://professional.heart.org/professional/EducationMeetings/MeetingsLiveCME/ScientificSessions/UCM_316900_Scientific-Sessions.jsp</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>43000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre for Research Excellence</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>1D760B2F-4C09-4178-96F2-6F7B99EA88D8</gtr:id><gtr:outcomeId>58b7f1eb91e8d0.59831886</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>234000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Training Fellowship</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9CC7AD22-7F0C-466F-9548-2FBE956BCAC1</gtr:id><gtr:outcomeId>5433e0289eee52.38399576</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE Guideline: Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>NICE Guideline (CG181): Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease</gtr:guidelineTitle><gtr:id>32699BAD-051D-459A-84F8-0207070C3CC3</gtr:id><gtr:impact>Stains should be considered for a much wider group of patients, including those with diabetes and chronic kidney disease and if there estimated 10-year risk of cardiovascular disease is 10% or more.</gtr:impact><gtr:outcomeId>543575cf2b7655.43356003</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.nice.org.uk/guidance/cg181</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Network of Hubs for Trials Methodology Research: Development of novel analysis methods in a systematic meta-analysis allowing indirect comparisons</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B1A4D4C5-77C5-4657-9501-7CF182AEDA08</gtr:id><gtr:impact>The Vascular Overviews Group which runs various collaborative meta-analyses including the Cholesterol Treatment Trialists' Collaboration, Anti-thrombotic Treatment Trialists' Collaboration and, the more recently set up, Coxib and traditional NSAID Trialists' (CNT) Collaboration has continued its work on several fronts leading to a high profile publication in the Lancet in 2013 on the vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs. A novel element of these analyses was that treatment effects were estimated by comparing the results of trials of a coxib versus placebo and trials of a coxib versus traditional NSAID. The conditions under which such indirect comparisons might be expected to yield valid results were satisfied, since the two sets of trials involved similar doses of coxibs and similar populations, and different studies used the same (high-dose) tNSAID regimens as comparators. This enabled the quantification of the hazards of various NSAIDs which had been substantially uncertain in the past. This work was widely reported in the scientific and lay media.</gtr:impact><gtr:outcomeId>544f70f53354e9.71792812</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>American Diabetes Association indications for statins in diabetes</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:guidelineTitle>American Diabetes Association indications for statins in diabetes (Diabetes Care 2009; 32: S384-91)</gtr:guidelineTitle><gtr:id>A8870053-7671-43C7-960A-8A59CA250CEF</gtr:id><gtr:impact>Recommendation from ADA that all patients with diabetes receive a statin and that the target LDL cholesterol among them should be &amp;lt;2.6 mmol/L</gtr:impact><gtr:outcomeId>54356c657f48e6.38834343</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Medicines Agency recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>309A0CB4-38AC-4032-BFDB-6542B98D1A27</gtr:id><gtr:impact>Our 2013 Lancet publication (see below) was cited in the press release as providing the new evidence that resulted in the EMA issuing updated guidance.

Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 30 May 2013 doi:10.1016/S0140-6736(13)60900-9</gtr:impact><gtr:outcomeId>544e1a63640a60.13249771</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type><gtr:url>http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/news_detail_001816.jsp&amp;mid=WC0b01ac058004d5c1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Guidelines on Cardiovascular Disease Prevention in Clinical Practice</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:guidelineTitle>European Guidelines on Cardiovascular Disease Prevention in Clinical Practice</gtr:guidelineTitle><gtr:id>1B6B8680-F468-493D-87BF-AAD3579D39E6</gtr:id><gtr:impact>ESC clinical guidelines influence the management of cardiovascular disease in both primary and secondary care.</gtr:impact><gtr:outcomeId>543570eb55c163.03007985</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5603B6C0-D9D8-4E51-A373-817A47143E3B</gtr:id><gtr:title>Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/422e300a7c5463cf3187c6b8452775db"><gtr:id>422e300a7c5463cf3187c6b8452775db</gtr:id><gtr:otherNames>Antithrombotic Trialists' (ATT) Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>541aad77dda586.49460685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E337E17-B0C9-4D87-9EF7-9E6EE22459D4</gtr:id><gtr:title>Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de0c7acc1b1b788058c085cccf18b134"><gtr:id>de0c7acc1b1b788058c085cccf18b134</gtr:id><gtr:otherNames>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>541aad74978d16.75022093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30066343-7973-48EB-8EF5-1E697C808676</gtr:id><gtr:title>Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f67a36f4c44c4922a18eaf376974507b"><gtr:id>f67a36f4c44c4922a18eaf376974507b</gtr:id><gtr:otherNames>Whiteley WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58b6b5f526eee4.73056703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>236D7165-2E58-4E12-B97D-8AC2C43E1439</gtr:id><gtr:title>Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).</gtr:title><gtr:parentPublicationTitle>American journal of kidney diseases : the official journal of the National Kidney Foundation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78bf4acd842867687b701ca1c29e8cd9"><gtr:id>78bf4acd842867687b701ca1c29e8cd9</gtr:id><gtr:otherNames>Staplin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0272-6386</gtr:issn><gtr:outcomeId>58b6b5f4a07df7.56883878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8926FCD9-6D79-4056-B97B-69E5F69A0998</gtr:id><gtr:title>Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f53abbd2857ddb15bd313e00c73cef5"><gtr:id>7f53abbd2857ddb15bd313e00c73cef5</gtr:id><gtr:otherNames>Lees KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>58b6b5f5a41145.31252396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23011814-300A-415B-9956-74AF8D4CF24D</gtr:id><gtr:title>2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9000b50e8bfbe1acd70cd0ebb25404"><gtr:id>9c9000b50e8bfbe1acd70cd0ebb25404</gtr:id><gtr:otherNames>Roffi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>56d86505ebce60.58339555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DBD8B53-F59C-4FBC-B747-8B7FD31DC9B5</gtr:id><gtr:title>Efficacy and safety of more intensive lowering of LDL cholesterol - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17db3abbe0db607e59b90682b233cf57"><gtr:id>17db3abbe0db607e59b90682b233cf57</gtr:id><gtr:otherNames>Baigent C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>541aad7e4a7863.40402478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD516C6F-48BB-488E-8914-B8D87BB4B23C</gtr:id><gtr:title>Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1a8cb1809bcdabab92d0c99435e9eb2"><gtr:id>f1a8cb1809bcdabab92d0c99435e9eb2</gtr:id><gtr:otherNames>De Caterina R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>58b6b5f4521e50.00444669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47C4CD07-4834-495D-98EE-2D1C600CAB06</gtr:id><gtr:title>Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a3a1ba1db06169790747f108a95af4f"><gtr:id>9a3a1ba1db06169790747f108a95af4f</gtr:id><gtr:otherNames>Wong G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>58b6b5f57bba86.04662120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B31B93B-164B-4F40-ACC0-67B18E4B54A1</gtr:id><gtr:title>Statins for people at low risk of cardiovascular disease - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df74d66b919618634773d74760eabc5"><gtr:id>2df74d66b919618634773d74760eabc5</gtr:id><gtr:otherNames>Mihaylova B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>541aad77393d02.17459036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D645E92-5682-4A92-8347-46ECF07D06BA</gtr:id><gtr:title>Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da90cc45e04dfc83bfec5febb3041423"><gtr:id>da90cc45e04dfc83bfec5febb3041423</gtr:id><gtr:otherNames>Stroke Thrombolysis Trialists' Collaborative Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>541aad7c8c3276.14810128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9BAD5AB-967F-4938-87EE-6C733B68D186</gtr:id><gtr:title>Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e629203f5aba505ea66c7c8006db015"><gtr:id>3e629203f5aba505ea66c7c8006db015</gtr:id><gtr:otherNames>Coxib and traditional NSAID Trialists' (CNT) Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>541aaa6b18ed59.48979479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9081E2B3-6670-46CB-AA2F-93ACEBBDD3F7</gtr:id><gtr:title>Antiplatelet agents for the treatment and prevention of atherothrombosis.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3095e5f245a9b4155f07a1154b0c7ea"><gtr:id>f3095e5f245a9b4155f07a1154b0c7ea</gtr:id><gtr:otherNames>Patrono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>541aad7da9ba96.38153046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA7F7C0F-9780-4F7A-A55A-E9F622032F28</gtr:id><gtr:title>Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de0c7acc1b1b788058c085cccf18b134"><gtr:id>de0c7acc1b1b788058c085cccf18b134</gtr:id><gtr:otherNames>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_15419_29_21067804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E25A8B5A-D0C4-4640-87E1-3F75880F3A67</gtr:id><gtr:title>Lessons from the controversy over statins - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e076c6ecf685f11a5d56959e53d3dce0"><gtr:id>e076c6ecf685f11a5d56959e53d3dce0</gtr:id><gtr:otherNames>Armitage J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b6b7a8e82f17.35846142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>325CCF93-9320-4BA8-942D-806D54FDB7CD</gtr:id><gtr:title>Selective COX-2 inhibitors: where do we go from here?</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17db3abbe0db607e59b90682b233cf57"><gtr:id>17db3abbe0db607e59b90682b233cf57</gtr:id><gtr:otherNames>Baigent C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>541aad78570551.58814093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ECFC26C-C87C-42DF-A2EA-171B981C0222</gtr:id><gtr:title>Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e2deb820b6a5886cf3ea808012b9fb1"><gtr:id>8e2deb820b6a5886cf3ea808012b9fb1</gtr:id><gtr:otherNames>Scally B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aa10b6feea440.32864992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6401E408-7367-4B05-9020-0D9BE55D4C02</gtr:id><gtr:title>Are statins useful in patients with advanced chronic kidney disease? - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet Diabetes &amp; Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/079aafb069c9dcc3b9193c395648f372"><gtr:id>079aafb069c9dcc3b9193c395648f372</gtr:id><gtr:otherNames>Herrington W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b6b7a9415e31.38882640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B787AA9-5463-4CB8-ADD3-286B4D2AE5D0</gtr:id><gtr:title>General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1a8cb1809bcdabab92d0c99435e9eb2"><gtr:id>f1a8cb1809bcdabab92d0c99435e9eb2</gtr:id><gtr:otherNames>De Caterina R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>541aaa69e09123.33264257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EF63829-E171-4BC9-923A-72BC1637778D</gtr:id><gtr:title>Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1a8cb1809bcdabab92d0c99435e9eb2"><gtr:id>f1a8cb1809bcdabab92d0c99435e9eb2</gtr:id><gtr:otherNames>De Caterina R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>541aaa6a222329.30066153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C73C51A4-85BD-4EE9-8929-6A41EA8CF5D6</gtr:id><gtr:title>International Encyclopedia of Public Health</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17db3abbe0db607e59b90682b233cf57"><gtr:id>17db3abbe0db607e59b90682b233cf57</gtr:id><gtr:otherNames>Baigent C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:isbn>9780123739605</gtr:isbn><gtr:outcomeId>541aaa6b532cb8.57461798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>420FB9B5-73F5-4A49-B408-8628C80779D6</gtr:id><gtr:title>Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.</gtr:title><gtr:parentPublicationTitle>American heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de0c7acc1b1b788058c085cccf18b134"><gtr:id>de0c7acc1b1b788058c085cccf18b134</gtr:id><gtr:otherNames>Cholesterol Treatment Trialists' (CTT) Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-8703</gtr:issn><gtr:outcomeId>58b6bc458941e1.17232778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9841153F-0CDC-429D-91EC-A142FF00DC5F</gtr:id><gtr:title>Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1a8cb1809bcdabab92d0c99435e9eb2"><gtr:id>f1a8cb1809bcdabab92d0c99435e9eb2</gtr:id><gtr:otherNames>De Caterina R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>541aa8bce912d6.16248170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E1457D7-DDE7-4F40-8396-ED0437AB1039</gtr:id><gtr:title>Evidence for the prevention and treatment of stroke in dialysis patients.</gtr:title><gtr:parentPublicationTitle>Seminars in dialysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/079aafb069c9dcc3b9193c395648f372"><gtr:id>079aafb069c9dcc3b9193c395648f372</gtr:id><gtr:otherNames>Herrington W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0894-0959</gtr:issn><gtr:outcomeId>56d86503204018.51064300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>731804E4-6453-4472-B83F-F3EE1A96E416</gtr:id><gtr:title>Nonsteroidal anti-inflammatory drugs and the heart.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3095e5f245a9b4155f07a1154b0c7ea"><gtr:id>f3095e5f245a9b4155f07a1154b0c7ea</gtr:id><gtr:otherNames>Patrono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>541aad7bda7b22.74730807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFC50715-397A-4F31-862A-FA47681F2888</gtr:id><gtr:title>New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1a8cb1809bcdabab92d0c99435e9eb2"><gtr:id>f1a8cb1809bcdabab92d0c99435e9eb2</gtr:id><gtr:otherNames>De Caterina R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>540ef8bd42e8a5.01134262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41C4DFB0-F9CC-465D-B596-7CC2AF426AE1</gtr:id><gtr:title>Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01a50d6dd425eaa7a6e921ca2fc8a17d"><gtr:id>01a50d6dd425eaa7a6e921ca2fc8a17d</gtr:id><gtr:otherNames>Cholesterol Treatment Trialists' (CTT) Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_15419_19_18191683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3794AC6-5CC5-457D-AC0F-3BB91BC7B191</gtr:id><gtr:title>Statins and diabetes - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bc068b805c8c160e0670be91991fb9"><gtr:id>a3bc068b805c8c160e0670be91991fb9</gtr:id><gtr:otherNames>Kearney P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>541aad788a45f3.34544218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A0A4006-2CB6-438C-B66B-42082BEA31B2</gtr:id><gtr:title>Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f467930482c1fdb4e79d78b295a81332"><gtr:id>f467930482c1fdb4e79d78b295a81332</gtr:id><gtr:otherNames>Gross O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>58b6b5f4d66432.68245880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49776A62-C1D2-4D51-9F83-F05FCC32B057</gtr:id><gtr:title>Coxibs and traditional NSAIDs for pain relief - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93e3ab2ce143cf4cee2128e6b8e79122"><gtr:id>93e3ab2ce143cf4cee2128e6b8e79122</gtr:id><gtr:otherNames>Bhala N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>541aaa6adab4f5.94259508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EAD6D0A-72C5-40A2-A54F-1FD90EC84216</gtr:id><gtr:title>Thrombolysis in acute stroke - Authors' reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d92ef546ea273952a7cfddeb17749e"><gtr:id>27d92ef546ea273952a7cfddeb17749e</gtr:id><gtr:otherNames>Emberson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d865049c3554.98112626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70339053-A023-4274-BF18-4AB641A92B23</gtr:id><gtr:title>Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3095e5f245a9b4155f07a1154b0c7ea"><gtr:id>f3095e5f245a9b4155f07a1154b0c7ea</gtr:id><gtr:otherNames>Patrono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>541aad7a0408a4.20237509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C62E6F-236E-4041-8651-E896E254D1D3</gtr:id><gtr:title>Aspirin for Disease Prevention: Public Policy or Personal Choice?</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17db3abbe0db607e59b90682b233cf57"><gtr:id>17db3abbe0db607e59b90682b233cf57</gtr:id><gtr:otherNames>Baigent C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>58b6b5f47581c8.48028282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35C7E241-EDB5-4B37-85E8-C48D2859AB91</gtr:id><gtr:title>Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.</gtr:title><gtr:parentPublicationTitle>American heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4a4da45fda43b7bf4cf1248cb0ab42d"><gtr:id>b4a4da45fda43b7bf4cf1248cb0ab42d</gtr:id><gtr:otherNames>Pitcher A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-8703</gtr:issn><gtr:outcomeId>56d8650500f2a9.60504406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4449E4DA-AD6F-4E3B-8AA9-D9690FD67F21</gtr:id><gtr:title>Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d92ef546ea273952a7cfddeb17749e"><gtr:id>27d92ef546ea273952a7cfddeb17749e</gtr:id><gtr:otherNames>Emberson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>541ab02ab99f16.10590208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E757C917-415C-40F5-A10D-FF281A003A23</gtr:id><gtr:title>The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01a50d6dd425eaa7a6e921ca2fc8a17d"><gtr:id>01a50d6dd425eaa7a6e921ca2fc8a17d</gtr:id><gtr:otherNames>Cholesterol Treatment Trialists' (CTT) Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_15419_29_22607822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB50B26C-4ECE-4FED-9D36-DF91BD3AC266</gtr:id><gtr:title>Aspirin in the primary prevention of vascular disease - ATT secretariat's reply</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17db3abbe0db607e59b90682b233cf57"><gtr:id>17db3abbe0db607e59b90682b233cf57</gtr:id><gtr:otherNames>Baigent C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>541aad7e7a17f6.28445042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8668FB05-9383-41EB-BE15-A27C12ED9AF4</gtr:id><gtr:title>Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP).</gtr:title><gtr:parentPublicationTitle>Clinical journal of the American Society of Nephrology : CJASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78bf4acd842867687b701ca1c29e8cd9"><gtr:id>78bf4acd842867687b701ca1c29e8cd9</gtr:id><gtr:otherNames>Staplin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1555-9041</gtr:issn><gtr:outcomeId>58b6b5f5d955d1.62212028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB161493-17B2-4898-9FE6-1192EF4816A5</gtr:id><gtr:title>Interpretation of the evidence for the efficacy and safety of statin therapy.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5079851905ee4c5f671c1e3e5a037c87"><gtr:id>5079851905ee4c5f671c1e3e5a037c87</gtr:id><gtr:otherNames>Collins R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58b6b5f60ac9d2.54348425</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137686849</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>0CDFB83C-594C-4860-B0BE-C82CA4D45B6B</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>